Page last updated: 2024-08-23

paroxetine and Depression

paroxetine has been researched along with Depression in 337 studies

Research

Studies (337)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	43 (12.76)	18.2507
2000's	161 (47.77)	29.6817
2010's	114 (33.83)	24.3611
2020's	19 (5.64)	2.80

Authors

Authors	Studies
Cui, P; Hao, L; He, X; Jia, Y; Liang, Z; Tong, B; Yang, F; Yuan, J; Zhao, L; Zhu, R	1
Diao, Y; Dong, J; Fu, Y; Geng, M; Gu, J; Liu, C; Liu, X; Mu, J; Wang, C; Wang, H	1
Fang, M; Feng, Y; Liu, S; Mayes, TL; Wang, G; Xiao, L; Zhou, J	1
Bykov, K; Gagne, JJ; Yoshida, K; Yunusa, I	1
Gong, A; Wu, Z; Zeng, M	1
Ikenouchi, A; Okamoto, N; Yoshimura, R	1
Chen, H; Cui, Z; Gao, Z; Hong, J; Li, X; Ma, Y; Ning, L; Tong, T; Wang, X; Wang, Z; Xuan, B; Yan, Y	1
Chen, M; Fan, J; Guo, C; Liu, W; Liu, Y; Lu, H; Xu, J; Yang, J; Zhang, H	1
Cao, Q; Rao, Y; Yang, R; Zhao, J	1
Chen, YM; Guan, W; Huang, J; Jiang, B; Li, WY; Shi, TS; Xu, DW	1
Bressolle-Gomeni, F; Fava, M; Gomeni, R	1
Chen, ML; Gou, L; Jiang, DQ; Jiang, LL; Mo, Y; Wang, Y; Wu, YL; Zang, QM	1
Konstantinou, G; Mylona, S; Paschalakis, G; Stavrinou, A; Vasilopoulou, P	1
Appeldoorn, JTY; Mulder, H; Risselada, AJ; Ruhé, EG; Schene, AH; Simoons, M; van Roon, EN; van Schaik, RHN	1
Garabadu, D; Krishnamurthy, S; Prajapati, SK; Singh, N	1
Červeňová, J	1
Han, L; Han, Z; Li, L; Yan, B	1
Bates, DW; Buckeridge, DL; Dixon, WG; Girard, N; Haas, JS; Habib, B; Iqbal, U; Li, J; Sheppard, T; Tamblyn, R	1
Airaksinen, J; Elovainio, M; García Velázquez, R; Gluschkoff, K; Jokela, M; Komulainen, K; Savelieva, K	1
Adams, A; Baethge, C; Braun, C; Bschor, T; Kuhr, K; Rink, L	1
Bambico, FR; Blundell, J; Conway, JD; Dinesh, OC; Hasan, SN; Nobrega, JN; Raymond, R; Waye, SC	1
Aksoy, S; Atıcı, M; Erdogan, MS; Ertaş, ET; Isa Kara, M; Kelebek, S; Ozen, E	1
Campbell Burton, CA; Chun, HY; Gillespie, D; Holmes, J; Knapp, P; Lewis, SR; Lightbody, CE; Murray, J; Watkins, CL	1
Jiao, Y; Liang, Y; Lin, J; Qu, H; Sun, Y; Xu, J; Zhao, C	1
Chen, XF; Gao, NN; Jin, ZL; Li, XR; Li, YF; Ran, YH; Xiong, J; Zheng, YY	1
Agius, M; Ripullone, K; Womersley, K	1
Farooq, AD; Naqvi, S; Rahman, R; Zeb, F	1
Chen, CY; Ho, PS; Huang, CC; Huang, SY; Kuo, SC; Liang, CS; Lu, RB; Shyu, JF; Yeh, YW; Yen, CH	1
Frokjaer, VG; Galea, LAM; Lieblich, SE; Overgaard, A; Richardson, R	1
He, JC; Pu, ZP; Xia, JM; Xie, W	1
Beyer, JL; Johnson, KG	1
Cizmarikova, M; Dragasek, J; Kolarcik, P; Mojzis, J; Vancova, Z; Zofcakova, S	1
Dong, ZQ; Kuang, WH; Li, J; Tian, LT	1
Li, P; Ma, C	1
Cai, H; Gong, X; Guo, Y; Han, W; Jiang, P; Liao, D; Liu, M	1
Boudreau, DM; Crane, PK; Edwards, KL; Fullerton, SM; Gray, SL; Heath, L; Larson, EB; Thummel, K	1
Bleau, P; Hedeker, H; Moskowitz, DS; Pinard, G; Rappaport, LM; Russell, JJ	1
Carson-Chahhoud, KV; Pollok, J; van Agteren, JE	1
Bassi, M; Cauli, G; Gala, C; Iapichino, E; Marconi, AM; Quartieri Bollani, M; Rucci, P	1
Clinton, SM; Glover, ME; Jackson, NL; McCoy, CR; Shupe, EA; Unroe, KA	1
Cossu, AE; Hardacker, DM; Jea, AH; Latham, LB	1
Gong, L; Yin, Y; Yue, L; Zhang, X	1
Callegari, C; Caselli, I; Diurni, M; Ielmini, M; Isella, C; Lucca, G; Pettenon, F; Poloni, N	1
Cipriani, A; Furukawa, TA; Ikeda, K; Imai, H; Maruo, K; Noma, H; Shinohara, K; Tanaka, S; Yamawaki, S	1
Eriksson, E; Hieronymus, F; Lisinski, A; Nilsson, S	1
Arterburn, D; Bogart, A; Boudreau, DM; Haneuse, S; Simon, G; Theis, MK; Westbrook, E	1
Casarotto, PC; Guimarães, FS; Hiroaki-Sato, VA; Joca, SR; Pereira, VS; Sartim, AG	1
Juřica, J; Žourková, A	1
Amsterdam, JD; DeRubeis, RJ; Fournier, JC; Gallop, R; Hollon, SD; Shelton, RC	1
Berk, M; Dodd, S; Kelin, K; Mancini, M; Schacht, A	1
Bhatt, S; Devadoss, T; Jindal, A; Mahesh, R	1
Hong, L; Lin, YN; Lu, XY; Ng, SM; Wang, F; Wang, WD; Zhao, Y	1
Hou, XJ; Wang, J; Xu, JH; Yu, YY	1
Achacoso, N; Friedman, GD; Habel, LA; Kroenke, CH; Meng, MV; Schwalbe, J	1
Montgomery, SA; Reines, EH; Sanchez, C	1
Dienel, A; Gastpar, M; Kasper, S; Möller, HJ; Müller, WE; Schläfke, S; Volz, HP	1
Auinger, P; Christine, CW; Factor, SA; Juncos, J; Leentjens, AF; Lyness, JM; Marsh, L; McDonald, W; Moonen, AJ; Panisset, M; Pfeiffer, R; Richard, IH; Rottenberg, D; Serrano Ramos, C; Shulman, L; Singer, C; Slevin, J; Wijers, A	1
Barbui, C; Cipriani, A; Furukawa, TA; Gastaldon, C; Magni, LR; Papola, D; Purgato, M; Rizzo, C; Trespidi, C; Watanabe, N	1
Bennett, KL; Berger, J; Ghafari, M; Kotlowski, C; Kotlowsky, C; Lubec, G; Miklósi, AG; Schmuckermair, C; Singewald, N; Whittle, N	1
Hu, MY; Jia, LL; Li, F; Liu, C; Liu, L; Liu, XD; Xu, D; Yang, Y; Zhang, M; Zhong, ZY	1
Amsterdam, J; DeRubeis, RJ; Fournier, JC; Hollon, SD; Shelton, RC	1
Baltes, BB; Grekin, ER; Kirsch, I; Loree, AM; Sugarman, MA	1
Fukunaga, K; Han, F; Izumi, H; Moriguchi, S; Sakagami, H; Sasaki, Y; Yabuki, Y; Zhang, C	1
Balsevich, G; Dedic, N; Deussing, JM; Eder, M; Gassen, NC; Hafner, K; Hartmann, J; Holsboer, F; Ising, M; Kirmeier, T; Kloiber, S; Kollmannsberger, L; Lucae, S; Rein, T; Schmidt, MV; Stepan, J; Uhr, M; Wagner, KV; Zellner, A; Zschocke, J	1
Bétry, C; Bundgaard, C; Haddjeri, N; Mørk, A; Overstreet, D; Pehrson, AL; Sanchez, C	1
Gassen, NC; Hartmann, J; Rein, T; Schmidt, MV	1
De Gobbi, JI; Matsubara, BB; Matsubara, LS; Omoto, AC; Roscani, MG; Siqueira, TF	1
Blanco, C; Cohen, JN; Drabick, DA; Heimberg, RG; Liebowitz, MR; Potter, CM; Schneier, FR	1
Dong, C; Hashimoto, K; Hirota, S; Inanaga, K; Yao, W; Zhang, JC; Zhuang, C	1
Barahona-Corrêa, B; Lampreia, T; Leitão, C; Mendonça, MD	1
Files, JA; Jenkins, MR; Kransdorf, LN; McNeil, MA	1
Azrael, D; Bushnell, GA; Miller, M; Pate, V; Stürmer, T; Swanson, SA; White, A	1
Binder, EB; Carell, T; Carrillo-Roa, T; Chrousos, GP; Fries, GR; Gassen, NC; Hafner, K; Hartmann, J; Hoeijmakers, L; Ising, M; Kloiber, S; Knop, M; Lucae, S; Preißinger, SN; Rein, T; Rüegg, J; Schmidt, MV; Steinbacher, J; Weber, F; Zannas, AS; Zschocke, J	1
Ali, J; Baboota, S; Gupta, BK; Kumar, S; Pandey, YR	1
Ahmed, SA; Avila, C; Cheetham, TC; Chung, J; Fletcher, SW; Habel, LA; Haque, R; Kleinman, K; Kwan, ML; Schottinger, JE; Shi, J	1
Baker, H	1
Broen, MP; Köhler, S; Kuijf, ML; Leentjens, AF; McDonald, WM; Richard, IH	1
Barbui, C; Barth, M; Cipriani, A; Klostermann, S; Kriston, L; Linde, K	1
Ramzy, EA	1
Bagmetova, VV; Chernysheva, YV; Ozerov, AA; Tyurenkov, IN	1
Brüning, CA; Duarte, T; Mantovani, AC; Nogueira, CW; Pesarico, AP; Sartori, G; Zeni, G	1
Altamura, AC; Buoli, M; Ciappolino, V; Serati, M	1
Jia, L; Jiang, SM; Liu, J; Shi, MM; Xu, MZ	1
Huang, S; Liu, C; Liu, X; Ye, Y	1
Chen, DY; Gu, X; Jia, L; Jiang, SM; Xie, HL; Xu, J	1
Aparasu, RR; Bali, V; Carnahan, RM; Chatterjee, S; Chen, H; Johnson, ML	3
Amin, DF; Egberts, AC; Gardarsdottir, H; Heerdink, ER; Taxis, K; Wouters, H	1
Ahlgren, J; Fredriksson, I; Garmo, H; Holmberg, L; Sund, M; Valachis, A; Weinman, J	1
Ciliberto, M; De Crescenzo, F; Ebmeier, KP; Janiri, L; Menghini, D; Treglia, G	1
Derijks, HJ; Grootens, K; Jessurun, N; Mikes, O; Otten, LS; van Marum, RJ; van Puijenbroek, EP; Vermeulen Windsant, A	1
Chen, J; Deng, X; Fang, L; Lei, T; Lei, Y; Qu, Z; Zhang, L; Zhao, X; Zhong, J; Zhou, C; Zou, B	1
Bots, CP; Brand, HS; van Nieuw Amerongen, A	1
Evans, RW; Rosen, N	1
Kelly, BD	1
Deussing, JM; Henniger, MS; Holsboer, F; Kühne, C; Ohl, F; Paez-Pereda, M; Panhuysen, M; Pohl, T; Pütz, B; Sillaber, I	1
Bespalov, AY; Gross, G; Mezler, M; Schoemaker, H; Sukhotina, IA; van Gaalen, MM; Wicke, K	1
DU, HG; Fu, XC; Ma, GY; Zheng, H	1
Caccia, S; Calcagno, E; Canetta, A; Cervo, L; Fracasso, C; Guzzetti, S; Invernizzi, RW; Sacchetti, G	1
Breuer, ME; Campbell, U; Chan, JS; Groenink, L; Hanania, T; Korte, SM; Olivier, B; Oosting, RS; Schreiber, R; Snoeren, EM; Waldinger, M	1
Irahara, M; Kase, Y; Noguchi, M; Numata, S; Ohmori, T; Tsuchiya, N; Uemura, H; Ueno, S; Yamada, M; Yasui, T; Yuzurihara, M	1
Baldwin, DS; Boulenger, JP; Kasper, S; Larsson Lönn, S	1
David, DJ; Deltheil, T; Gardier, AM; Hen, R; Reperant, C; Tanaka, K	1
Glubb, DM; Joyce, PR; Kennedy, MA; McHugh, PC; Rogers, GR	1
Croghan, TW; Daniel, G; Erder, MH; Esposito, D; Stoto, MA; Wahl, P	1
Bienfait, K; Buyske, S; Dicke, A; Dobkin, RD; Gara, M; Marin, H; Mark, MH; Menza, M	1
Chiocchetti, B; Melani, F; Muscas, GC; Rosati, E	1
Aznar, S; Knudsen, GM; Licht, CL; Marcussen, AB; Overstreet, DH; Wegener, G	1
De Koning, FH; Derijks, HJ; Egberts, AC; Heerdink, ER; Janknegt, R; Krekels, MM; Looij, BJ	1
Lazzeroni, LC; Murphy, GM; Ryan, HS; Sarginson, JE; Schatzberg, AF	1
Goldstein, I; Kellner, CH; Korda, JB; Pfaus, JG	1
Ceylan, ME; Ozer, U; Turkcan, A	1
Belitser, SV; Egberts, TC; Schobben, AF; Ververs, FF; Visser, GH; Voorbij, HA; Zwarts, P	1
Corti, N; Elke, B; Locher, P; Wagner, CC	1
Goldstein, MR; Mascitelli, L; Pezzetta, F	1
Governale, L; Hammad, TA; Kaplan, S; Mosholder, AD; Pamer, CA; Rochester, G; Wu, YT	1
Chen, W; Geng, D; Huang, Y; Li, Y; Shi, X; Wu, X	1
Gay, BM; Nogueira, CW; Prigol, M; Stein, AL	1
Ershoff, BD; Lazzeroni, LC; Murphy, GM; Ryan, HS; Sarginson, JE; Schatzberg, AF	1
Bishop, JR; Ellingrod, VL; Keiser, MJ; Thomas, KL	1
Antonioli, L; Blandizzi, C; Colucci, R; Corona, T; Fornai, M; Mantarro, S; Montagnani, S; Pergola, A; Ruggiero, E; Scollo, C; Testi, A; Tuccori, M	1
Einarson, A	1
Fukui, N; Ono, S; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J	1
Chen, WQ; Li, L; Lubec, G; Sartori, SB; Singewald, N; Whittle, N; Yang, JW	1
De Keyser, J; Glazenborg, A; Koch, MW; Mostert, J; Uyttenboogaart, M	1
Franco Hidalgo, S; Ginés Santiago, A; Nalotto, L; Prieto De Paula, JM	1
Hata, M; Kawachi, H; Minami, K; Murakami, T; Sezai, A; Shiono, M; Takasaka, A; Wakui, S; Yagi, Y; Yoshitake, I	1
Fang, Y; Jia, Y; Lian, Y; Wei, J; Xu, Y; Zeng, Z; Zhang, L; Zhao, X; Zhu, H	1
DeRogatis, LR; Fabre, LF; Smith, LC	1
Fitzgerald, P; Hannon, B; Murphy, M	1
Kaneda, A; Kaneko, S; Nakagami, T; Sato, Y; Yasui-Furukori, N	1
Cuestas, E; Cuestas, ME	1
Bermudez, I; Franklin, M; Gaburro, S; Murck, H; Singewald, N	1
Gibiino, S; Serretti, A	1
Barbato, A; Bortolotti, A; D'Avanzo, B; Fortino, I; Franchi, C; Merlino, L; Nobili, A; Parabiaghi, A; Tettamanti, M	1
Goto, F; Ogawa, K; Tsutsumi, T	1
Bazanella Sampaio, T; Mozzaquatro Gai, B; Nogueira, CW; Pinton, S; Trevisan da Rocha, J; Zeni, G	1
Khasanov, NR; Khasanova, DR; Oslopov, VN; Safiullina, AA; Zhitkova, IuV	1
Dilillo, D; Penagini, F; Pogliani, L; Schneider, L; Zuccotti, GV	1
Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; Imperadore, G; Purgato, M; Signoretti, A; Trespidi, C; Watanabe, N	1
Fiscella, K; Heckler, C; Innominato, PF; Janelsins, M; Kesler, S; Manber, R; Morrow, GR; Mustian, KM; Palesh, OG; Peppone, LJ; Roth, T; Sprod, LK	1
Hartmann, J; Holsboer, F; Labermaier, C; Liebl, C; Marinescu, D; Müller, MB; Scharf, SH; Schmidt, MV; Uhr, M; Wagner, KV; Wang, XD	1
Baldo, P; Cecco, S; Doree, C; McFerran, D; Molin, P	1
Komaroff, AL	1
Andrade, C	1
Barbui, C; Cipriani, A; Furukawa, TA; Koesters, M; Nosè, M; Omori, IM; Purgato, M; Trespidi, C	1
Bhatt, S; Devadoss, T; Jindal, A; Kumar, B; Mahesh, R; Pandey, DK	1
Claxton, A; Hackett, ML; Hankey, GJ; Hsieh, CF; Kutlubaev, MA; Lee, R; Mead, GE	1
Blum, WF; Colla, M; Daseking, E; Deuschle, M; Gilles, M; Heuser, I; Kopf, D; Krumm, B; Lederbogen, F; Schilling, C; Weber-Hamann, B; Wudy, SA	1
Li, L; Lin, M; Qian, MC; Shen, XH; Sun, JS; Yang, JH; Zhang, J; Zhong, H	1
Azuma, J; Kato, M; Kinoshita, T; Nonen, S; Serretti, A; Takekita, Y; Tetsuo, S	1
Chen, JQ; Huang, Y; Lin, WR; Wang, SX	1
Cunha, MP; Machado, DG; Oliveira, Á; Pazini, FL; Rodrigues, AL	1
Gouma, DJ; Koopman, MM; Levi, MM; Sewnath, ME; van Hillegersberg, R	1
Orr, KG; Osborne, SF; Stafford, L	1
Davenport, E; Velamoor, R	1
Christensen, J; Clemmensen, PM; Dalsgaard, NJ; Dam, H; Hindberg, I; Lunde, M; Mellerup, E; Plenge, P; Rasmussen, A	1
Chaudhry, HR; Qureshi, Z; Tareen, IA; Yazdani, I	1
Boutilier, AS; Gardner, DM	1
Landgraf, R	1
Green, B	1
Bush, VL; Fone, KC; Marsden, CA; Middlemiss, DN	1
Eriksson, JG; Paile-Hyvärinen, M; Wahlbeck, K	2
Lanchote, VL; Queiroz, RH; Zainaghi, IA	1
Abbott, A	1
Hadasová, E; Zourková, A	1
Bourin, M; Dailly, E; David, DJ; Hascoët, M; Ripoll, N	1
Lebert, F	1
Kremer, C; Murphy, GM; Rodrigues, H; Schatzberg, AF	1
Miller, A; Musselman, DL; Somerset, WI; Stout, SS	1
Capuron, L; Fuchs, D; Lawson, DH; Miller, AH; Musselman, DL; Nemeroff, CB; Neurauter, G	1
Broocks, A; Hohagen, F; Kordon, A	1
Brooks, SJ; Krulewicz, SP; Kutcher, S	1
Andrews, PL; Banerjee, TK; Flynn, PJ; Hickok, JT; Hynes, HE; King, DK; Kirshner, JJ; Morrow, GR; Raubertas, RF; Roscoe, JA	1
Hausner, RS	1
Rosner, MH	1
Kondro, W; Sibbald, B	1
Katsu, H; Nakayama, K; Ochiai, Y; Okino, S; Wakutsu, N	1
Cryan, JF; Dalvi, A; Friedland, JC; Hirsch, BR; Jin, SH; Lucki, I; O'Leary, OF; Ouyang, M; Page, ME; Thomas, SA	1
Jägestedt, M; von Bahr, C	1
Wadman, M	1
Horii, A; Kitahara, T; Kubo, T; Mitani, K; Takeda, N; Uno, A	1
Ramchandani, P	1
Arita, S; Morishita, S	3
Agren, H; Hägglöf, B; Lundin, B; Waern, M	1
Akinci, A; Kaymak, SU; Onat, AM; Ozçakar, L; Ureten, K	1
Baldwin, DS; Bradley, BP; Brodrick, P; Mogg, K	1
Joo, MH; Kim, HJ; Kim, SG; Koo, JR; Lee, HS; Lee, SK; Lee, YK; Noh, JW; Oh, JE; Seo, JW; Son, BK; Yoon, JY	1
Andrews, AM; Perez, XA	1
Bushunow, P; Griggs, JJ; Hickok, JT; Matteson, SE; Morrow, GR; Mustian, KM; Qazi, R; Roscoe, JA; Smith, B	1
Hamada, R; Matsuoka, H; Nakajima, T; Okatsu, H; Osame, M; Wakita, M	1
Huande, L; Juan, H; Zhiling, Z	1
Harrison, D; Meng, F; Mullins, CD; Shaya, FT; Wang, J	1
Deuschle, M; Gilles, M; Härtter, S; Heuser, I; Hiemke, C; Kellner, S; Krumm, B; Shams, M	1
Egberts, AC; Heerdink, ER; Hugtenburg, JG; van Geffen, EC; van Hulten, RP	1
Aursnes, I; Gaasemyr, J; Natvig, B; Tvete, IF	1
Anghelescu, IG; Regen, F	1
Briley, KA; Goodale, ES; Gopal, KV; Hendea, OM	1
Goldney, RD	1
Leonard, BE; Myint, AM; O'Mahony, SM; Steinbusch, H	1
Kim, JJ; Kim, TS; Lee, C; Lee, CU; Lee, KU; Lee, SJ; Pae, CU; Paik, IH	1
Gorodnichev, AV; Kostiukova, EG; Mosolov, SN; Timofeev, IV	1
Dauphin, A; Gruwez, B; Tod, M	1
Hasegawa, H; Hirose, S; Lin, QS; Nakamura, K; Nishimura, H; Ohashi, A; Ohtsuji, M; Sawabe, K; Sugawara, Y; Tsurui, H; Xiu, Y	1
Davies, JT; Dunner, DL; Lipschitz, A; Pitts, CD	1
Goto, M; Kaji, K; Kakihara, S; Nakamura, J; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R	1
Bron, MS; Meng, F; Mullins, CD; Shaya, FT; Wang, J	1
Friede, T; Kieser, M	1
Chen, S; Gao, F; Manatunga, AK	1
Bruce, KR; Israel, M; Ng Ying Kin, NM; Steiger, H	1
Carluer, L; Defer, GL; Schupp, C	1
Bourin, M; Chenu, F; Dailly, E	1
Mani, H; Matsubara, H; Sakamoto, T; Sakatani, T; Shirayama, T; Yamamoto, T	1
Ivanets, NN; Kinkul'kina, MA	1
Baxter, LR; Brody, AL; Maidment, KM; Saxena, S	1
Himei, A; Okamura, T	1
Azuma, J; Fukuda, K; Fukuda, T; Ikenaga, Y; Kato, M; Kinoshita, T; Nobuhara, K; Okugawa, G; Takekita, Y; Wakeno, M; Yamashita, M	1
García-Hernández, MJ; Kotzalidis, GD; Persechino, S; Ricciardi, A; Ruberto, A; Ruiz-Doblado, S; Tatarelli, R; Trevisi, M	1
Lathi, RB; Shahine, LK	1
Begley, AE; Dew, MA; Houck, PR; Mazumdar, S; Mulsant, BH; Reynolds, CF; Scott, J; Tang, G	1
Berman, N; Bowden, CL; Frazer, A; Katz, MM	1
Anghelescu, IG; Kieser, M; Klement, S; Kohnen, R; Szegedi, A	1
Hamada, Y; Inatsugi, Y; Kusunoki, S; Miyamoto, K; Suzuki, H	1
Hirayasu, Y; Karashima, A; Otsuka, T; Shioya, H; Sugiyama, N; Togo, T; Uehara, K; Yoshimi, A	1
Aldushin, AA; Avedisova, AS; Brodin, VI	1
Calgüneri, M; Ertenli, I; Kaymak, SU; Kiraz, S; Onat, AM; Ozçakar, L; Oztürk, MA; Ureten, K	1
Hoelzl, U; Landgraf, R; Muigg, P; Neumann, I; Palfrader, K; Singewald, N; Wigger, A	1
Andor, G; Harcos, P; Horváth, S; Karányi, Z; Nagy, Z; Németh, G	1
Abe, T; Kato, S; Onishi, Y; Yamamoto, K	1
Fujito, H; Kamikawa, H; Li, G; Maekawa, A; Oku, E; Somehara, T; Tatebayashi, H; Tsuruta, T; Ueki, H; Yamada, S; Yang, C	1
Aubry, JM; Bertschy, G; Bondolfi, G; Eap, CB; Gervasoni, N; Gex-Fabry, M	1
Ahmed, M; Parameshwaran, A; Swamy, P	1
Cines, M; Gottlieb, SS; Greenberg, N; Katzen, S; Kop, WJ; Marshall, J; Minshall, S; Thomas, SA; Vesely, MR	1
Andreatini, R; Casarotto, PC	1
Boncompagni, G; Ferranti, A; Furlanetto, S; Mandrioli, R; Mercolini, L; Raggi, MA	1
Bar-Oz, B; Bérard, A; Boskovic, R; Einarson, A; Einarson, T; Koren, G; Malm, H; O'Brien, L	1
Dew, MA; Dombrovski, AY; Houck, PR; Lenze, EJ; Mulsant, BH; Pollock, BG; Reynolds, CF	1
Chen, ZQ; Ji, JL; Liu, WJ; Mei, QY; Pan, JY; Tao, M; Wang, YP; Wei, J; Zhang, N; Zhao, ZX; Zheng, AL	1
Bekele, NB; Shih, YC; Xu, Y	1
Gong, SH; Liu, JQ; Liu, JS; Liu, S; Shi, ZY; Zhang, GJ	1
Aviv, A; Barak, Y; Mazeh, D; Shahal, B; Zemishlani, H	1
Babak, S; Bergman, U; Bertilsson, L; Boldueva, S; Burbello, A; Goryachkina, K	1
Aichhorn, W; Bitterlich, W; Bondy, B; Geretsegger, C; Stelzig, R; Stuppaeck, C	1
Barbui, C; Cipriani, A; Furukawa, TA	1
Blackwood, D; Day, RK; Matthews, K; Reid, IC; Smith, D; Smith, G; Wilkie, MJ; Wolf, CR	1
Cohen, LS; Joffe, H; Petrillo, L; Rydzewski, M; Soares, CN; Somley, B; Viguera, AC; Yehezkel, R	1
Bravo-Mehmedbasić, A; Dzubur-Kulenović, A; Kucukalić, A	1
Akishita, M; Eto, M; Ota, H; Ouchi, Y; Yamaguchi, K; Yamaguchi, Y	1
Aisa, B; Del Rio, J; Elizalde, N; Gil-Bea, FJ; Lasheras, B; Ramírez, MJ; Tordera, RM	1
Janne, P; Lejeune, D; Reynaert, C; Vause, M; Zdanowicz, N	1
Clayton, AH; McGarvey, EL; Owens, JE	1
Fartacek, R; Geretsegger, C; Heim, M; Mair, M; Platz, T; Stuppaeck, CH	1
Gagiano, CA	1
Feighner, JP	1
Alarcón, J; Cabrera-Valdivia, F; García-Albea, E; Jiménez-Jiménez, FJ; Martínez-Junquera, G; Tejeiro, J	1
Meyer, C	1
Gammon, GD	1
Chan, CH; Chiu, HJ; Hong, CJ	1
Petty, KJ	1
van Campen, JP; Voets, AJ	1
Hayashi-Kuwabara, Y; Ikeda, Y; Izumi, J; Kiuchi, Y; Oguchi, K; Tanaka, Y; Washizuka, M; Yoshinaga, K	1
Meier, E; Sánchez, C	1
Gambini, O; Garghentini, G; Grassi, B; Lazzarin, A; Scarone, S	1
Oldroyd, J	1
Alvarez, P; Arranz, B; Menchón, JM; Navarro, MA; Oros, M; Rosel, P; Vallejo, J	1
Costentin, J; Passera, G; Vaugeois, JM; Zuccaro, F	1
Harry, B; Zimmerschied, JA	1
György, S; Kecskés, I; Kiss, GH; Pestality, P; Rihmer, Z	1
Cooper, TA; Gibbons, RB; O'Brien-Falls, K; Valcour, VG	1
Hengeveld, MW; Tuyl, JP; Van der Mast, RC; Van Kempen, GM; Verkes, RJ; Zwinderman, AH	1
Loge, JH; Ramstad, K; Sponheim, E	1
Buchalter, EN; Giambanco, V; Lantz, MS	1
Altamura, AC; Bignotti, S; Curreli, R; Pioli, R; Tura, G	1
Cryan, JF; Leonard, BE; McGrath, C; Norman, TR	2
Bourin, M; Redrobe, JP	1
Béïque, JC; Blier, P; de Montigny, C; Debonnel, G	1
Burke, WJ; Frank, MG; Hendricks, SE; Johnson, DR; Wieseler, JL	1
Navarro, R; Spangler, M; Valler, WE	1
Cohen, LJ	1
Draper, B; Meares, S	1
Bell, C; Nutt, D	1
Christensen, HD; Coleman, FH; Gonzalez, CL; Rayburn, WF	1
Hartman, EE; Parker, RA	1
Crawford, J; Ellis, MJ; Hanfelt, JJ; Hayes, DF; Isaacs, C; Kramer, R; Lawrence, W; Rowland, J; Stearns, V	1
Gregson, J	1
Fagan, M	1
Freisleder, FJ; Mayer-Rosa, J; Rüth, U; Schlamp, D	1
Barrett, J; Cornell, J; Frank, E; Katon, W; Oxman, T; Sengupta, A; Sullivan, M; Williams, JW	1
Antonini, A; Canesi, M; Mariani, CB; Pezzoli, G; Tesei, S; Zecchinelli, A	1
Fortmann, SP; Hayward, C; Killen, JD; Rothman, M; Schatzberg, AF; Strausberg, L; Sussman, L; Varady, A	1
Dew, MA; Hernandez, CR; Houck, PR; Mulsant, B; Pollock, BG; Reynolds, CF; Smith, GS	1
Leard-Hansson, J	1
Terluin, B; van Hout, H	1
Bird, H; Broggini, M	1
Robb-Nicholson, C	1
Watson, S; Young, A	1
Artigas, F; Colombo, C; Fazio, F; Gobbo, C; Messa, C; Moresco, R; Smeraldi, E; Zanardi, R	1
Erazo, N; Greil, W; Grohmann, R; Horvath, A; Sassim, N	1
Goicoechea, C; Martín, MI; Ormazábal, MJ; Sánchez, E	1
Cassano, GB; Conti, L; Dell'Osso, L; Gemignani, A; Marazziti, D; Pfanner, C; Presta, S; Rossi, A	1
Cook, IA; Leuchter, AF	1
Agid, O; Lerer, B; Shalev, AY	1
Barrett, JE; Cornell, JE; Frank, E; Hegel, MT; Katon, W; Oxman, TE; Sengupta, AS; Sullivan, M; Williams, JW	1
McNeil, C	1
Nakash, R; Overstreet, DH; Yadid, G; Zangen, A	1
Kuboki, T	1
Boskailo, E; Djuric-Bijedic, Z; Lewis, J; Pavkovic, I; Smajkic, A; Weine, S	1
Freydl, K; Hasegawa, S; Hennegan, E; Hilchie-Schmidt, C; Hines, D; Iwata, J; Kappler, R; Mok, C; Plotkin, BJ; Raffaelli, D; Rodos, JJ; Schrage, M	1
Antonucci, G; Bragoni, M; Coiro, P; De Angelis, D; Grasso, MG; Morelli, D; Paolucci, S; Rizzi, F; Troisi, E	1
Li, C; Liu, M; Wu, W	1
Bensasi, S; Houck, PR; Mazumdar, S; Miller, MD; Mulsant, BH; Nebes, R; Pollock, BG; Reynolds, CF; Stack, J; Sweet, RA	1
Contu, A; Moslinger-Gehmayr, R; Pezzella, G	1
Arbuzov, AL; Litvintsev, SV; Mironychev, GN; Reznik, AM	1
Mynors-Wallis, LM; Thornett, AM	1
Azadian, AG; Warnock, CA	1
Ismail, M; Lyster, G	1
Jacobsen, PB; Minton, S; Moncello, J; Weitzner, MA	1
Dimidjian, S; Katon, W; Schmaling, KB; Sullivan, M	1
Dunbar, GC; Stoker, MJ; Tignol, J	1
Edwards, E; Harkins, K; Henn, F; Wright, G	1
Brøsen, K; Eshøj, O; Gram, LF; Mogensen, EF; Sindrup, SH	1
Westwick, F	1

Reviews

41 review(s) available for paroxetine and Depression

Article	Year
Paroxetine combined with traditional chinese medicine prescriptions in the treatment of postpartum depression: A systematic review of randomized controlled trials. Frontiers in neuroendocrinology, 2022, Volume: 67 Topics: Depression; Depression, Postpartum; Female; Humans; Medicine, Chinese Traditional; Paroxetine; Prescriptions; Randomized Controlled Trials as Topic	2022
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2022, Aug-01, Volume: 51, Issue:4 Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride	2022
The effects of paroxetine therapy on depressive symptom and motor function in the treatment of depression with Parkinson's disease: A meta-analysis. Medicine, 2023, Aug-25, Volume: 102, Issue:34 Topics: Control Groups; Depression; Humans; Mental Status and Dementia Tests; Parkinson Disease; Paroxetine	2023
Effectiveness of Paroxetine for Poststroke Depression: A Meta-Analysis. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020, Volume: 29, Issue:5 Topics: Affect; Antidepressive Agents, Second-Generation; Depression; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Stroke; Time Factors; Treatment Outcome	2020
In search of a dose-response relationship in SSRIs-a systematic review, meta-analysis, and network meta-analysis. Acta psychiatrica Scandinavica, 2020, Volume: 142, Issue:6 Topics: Depression; Dose-Response Relationship, Drug; Fluoxetine; Humans; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2020
Interventions for treating anxiety after stroke. The Cochrane database of systematic reviews, 2017, 05-23, Volume: 5 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Buspirone; Depression; Humans; Middle Aged; Paroxetine; Pilot Projects; Psychotherapy; Randomized Controlled Trials as Topic; Relaxation Therapy; Stroke	2017
What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence. Psychiatria Danubina, 2017, Volume: 29, Issue:Suppl 3 Topics: Adult; Anxiety; Citalopram; Depression; Female; Humans; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Serotonin	2017
Advances in Pharmacotherapy of Late-Life Depression. Current psychiatry reports, 2018, 04-07, Volume: 20, Issue:5 Topics: Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Drug Resistance; Duloxetine Hydrochloride; Humans; Paroxetine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vortioxetine	2018
Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. The Cochrane database of systematic reviews, 2018, 12-19, Volume: 12 Topics: Antidepressive Agents, Tricyclic; Depression; Dizziness; Dyspnea; Exercise Tolerance; Forced Expiratory Volume; Humans; Nausea; Nortriptyline; Paroxetine; Placebos; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2018
Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials. Journal of affective disorders, 2019, 05-01, Volume: 250 Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Japan; Male; Middle Aged; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride	2019
Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder. Journal of affective disorders, 2013, Sep-05, Volume: 150, Issue:2 Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Paroxetine; Recurrence; Thiophenes; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride	2013
Can antidepressants prevent pegylated interferon-α/ribavirin-associated depression in patients with chronic hepatitis C: meta-analysis of randomized, double-blind, placebo-controlled trials? PloS one, 2013, Volume: 8, Issue:10 Topics: Antidepressive Agents; Antiviral Agents; Citalopram; Depression; Double-Blind Method; Hepatitis C, Chronic; Humans; Interferon-alpha; Paroxetine; Polyethylene Glycols; Randomized Controlled Trials as Topic; Ribavirin; Treatment Outcome	2013
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? International clinical psychopharmacology, 2014, Volume: 29, Issue:4 Topics: Allosteric Site; Animals; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder, Major; Drug Interactions; Evidence-Based Medicine; Humans; Models, Biological; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline	2014
Paroxetine versus other anti-depressive agents for depression. The Cochrane database of systematic reviews, 2014, Apr-03, Issue:4 Topics: Antidepressive Agents; Depression; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	2014
The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales. PloS one, 2014, Volume: 9, Issue:8 Topics: Antidepressive Agents, Second-Generation; Anxiety; Anxiety Disorders; Clinical Trials as Topic; Depression; Double-Blind Method; Humans; Panic Disorder; Paroxetine; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome	2014
Women's health 2015: an update for the internist. Cleveland Clinic journal of medicine, 2015, Volume: 82, Issue:11 Topics: Clinical Competence; Depression; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Women's Health	2015
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials. The British journal of psychiatry : the journal of mental science, 2016, Volume: 208, Issue:2 Topics: Antidepressive Agents; Citalopram; Depression; Depressive Disorder, Major; Humans; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	2016
May selective serotonin reuptake inhibitors (SSRIs) provide some benefit for the treatment of schizophrenia? Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:10 Topics: Antidepressive Agents; Antipsychotic Agents; Depression; Humans; Paroxetine; Schizophrenia; Selective Serotonin Reuptake Inhibitors	2016
Is Aging & mental health, 2017, Volume: 21, Issue:9 Topics: Aged; Aging; Blood Glucose; Brain; Case-Control Studies; Depression; Fluorodeoxyglucose F18; Humans; Paroxetine; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sleep Deprivation	2017
Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression. PloS one, 2017, Volume: 12, Issue:2 Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Clinical Trials as Topic; Data Interpretation, Statistical; Depression; Humans; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Venlafaxine Hydrochloride	2017
[Frequent drug interactions in old age]. Praxis, 2009, Oct-21, Volume: 98, Issue:21 Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Cytochrome P-450 Enzyme System; Depression; Diuretics; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Heart Failure; Humans; Metoprolol; Paroxetine; Polypharmacy; Risk Factors; Sulfonamides; Torsemide	2009
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update. Postgraduate medicine, 2010, Volume: 122, Issue:4 Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Maternal-Fetal Exchange; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Teratogens	2010
Pharmacologic treatment of depression in multiple sclerosis. The Cochrane database of systematic reviews, 2011, Feb-16, Issue:2 Topics: Adult; Antidepressive Agents; Depression; Desipramine; Humans; Multiple Sclerosis; Paroxetine; Randomized Controlled Trials as Topic	2011
Paroxetine for the treatment of depression: a critical update. Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:3 Topics: Animals; Antidepressive Agents, Second-Generation; Depression; Evidence-Based Medicine; Humans; Paroxetine; Patient Selection; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2012
Citalopram versus other anti-depressive agents for depression. The Cochrane database of systematic reviews, 2012, Jul-11, Issue:7 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depression; Humans; Morpholines; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2012
Antidepressants for patients with tinnitus. The Cochrane database of systematic reviews, 2012, Sep-12, Issue:9 Topics: Amitriptyline; Antidepressive Agents; Depression; Humans; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tinnitus; Trazodone; Trimipramine	2012
Duloxetine versus other anti-depressive agents for depression. The Cochrane database of systematic reviews, 2012, Oct-17, Volume: 10 Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Desvenlafaxine Succinate; Dibenzothiazepines; Duloxetine Hydrochloride; Fluoxetine; Humans; Paroxetine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Thiophenes; Venlafaxine Hydrochloride	2012
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. The Cochrane database of systematic reviews, 2012, Nov-14, Volume: 11 Topics: Adult; Anxiety; Citalopram; Cognition; Depression; Fluoxetine; Humans; Nervous System Diseases; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke; Stroke Rehabilitation	2012
Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report. Journal of clinical pharmacy and therapeutics, 2003, Volume: 28, Issue:1 Topics: Contraindications; Depression; Drug Interactions; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Serotonin Syndrome; Tryptamines	2003
Focus on paroxetine. Current medical research and opinion, 2003, Volume: 19, Issue:1 Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depression; Drug Interactions; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Substance Withdrawal Syndrome; Treatment Outcome	2003
[Serotonin reuptake inhibitors in depression of Alzheimer's disease and other dementias]. Presse medicale (Paris, France : 1983), 2003, Jul-26, Volume: 32, Issue:25 Topics: Aged; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Dementia; Depression; Fluoxetine; Humans; Neuropsychological Tests; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Time Factors; Trazodone	2003
Paroxetine use in medically ill patients. Psychopharmacology bulletin, 2003,Spring, Volume: 37 Suppl 1 Topics: Antidepressive Agents, Second-Generation; Depression; Disease; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2003
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania	2003
Suicide attempts in clinical trials with paroxetine randomised against placebo. BMC medicine, 2005, Aug-22, Volume: 3 Topics: Adult; Bayes Theorem; Depression; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted	2005
Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trials. Clinical therapeutics, 2005, Volume: 27, Issue:12 Topics: Adolescent; Adult; Aged; Delayed-Action Preparations; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index	2005
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clinical therapeutics, 2007, Volume: 29, Issue:5 Topics: Abnormalities, Drug-Induced; Adult; Amniocentesis; Antidepressive Agents, Second-Generation; Anxiety; Depression; Electrocardiography; Female; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimesters; Ultrasonography	2007
Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2008, Jan-29, Volume: 178, Issue:3 Topics: Acute Disease; Depression; Humans; Paroxetine; Patient Compliance; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors	2008
[Clinical effects of serotonin reuptake inhibitors--a review]. Fortschritte der Neurologie-Psychiatrie, 1994, Volume: 62 Suppl 1 Topics: Depression; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	1994
[Early internal treatment of mild depression]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:8 Topics: Depression; Fluvoxamine; Health Knowledge, Attitudes, Practice; Humans; Paroxetine; Physicians, Family; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Social Support; Suicide Prevention	2001
Paroxetine in the treatment of melancholia and severe depression. International clinical psychopharmacology, 1992, Volume: 7, Issue:2 Topics: Adult; Depression; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales	1992
Depression and selective serotonin reuptake inhibitors. British journal of hospital medicine, 1990, Volume: 44, Issue:5 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depression; Fluoxetine; Humans; Imipramine; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Paroxetine; Piperidines; Serotonin Antagonists	1990

Trials

78 trial(s) available for paroxetine and Depression

Article	Year
Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine. Aging, 2021, 10-05, Volume: 13, Issue:19 Topics: Acetamides; Adult; Aged; Aging; Antidepressive Agents, Second-Generation; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Middle Aged; Paroxetine	2021
Network dynamics of depressive symptoms in antidepressant medication treatment: secondary analysis of eight clinical trials. Molecular psychiatry, 2021, Volume: 26, Issue:7 Topics: Antidepressive Agents; Depression; Fluoxetine; Humans; Paroxetine; Prospective Studies	2021
Affect, interpersonal behaviour and interpersonal perception during open-label, uncontrolled paroxetine treatment of people with social anxiety disorder: a pilot study Journal of psychiatry & neuroscience : JPN, 2018, 11-01, Volume: 43, Issue:6 Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Anxiety; Depression; Female; Humans; Interpersonal Relations; Male; Middle Aged; Paroxetine; Phobia, Social; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Social Behavior; Social Perception; Young Adult	2018
Promoting the well-being of mothers with multidisciplinary psychosocial interventions in the perinatal period. Journal of affective disorders, 2019, 03-01, Volume: 246 Topics: Adult; Antidepressive Agents; Anxiety; Combined Modality Therapy; Depression; Depression, Postpartum; Female; Humans; Longitudinal Studies; Mothers; Paroxetine; Patient Acceptance of Health Care; Perinatal Care; Pregnancy; Pregnancy Complications; Psychotherapy; Risk Factors; Sertraline; Treatment Outcome	2019
Dynamics and persistence of CYP2D6 inhibition by paroxetine. Journal of clinical pharmacy and therapeutics, 2013, Volume: 38, Issue:4 Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Depression; Dextromethorphan; Dextrorphan; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Young Adult	2013
Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy. Behaviour research and therapy, 2013, Volume: 51, Issue:7 Topics: Affect; Antidepressive Agents; Anxiety; Cognition; Cognitive Behavioral Therapy; Depression; Humans; Paroxetine; Suicidal Ideation; Symptom Assessment	2013
Effects of electro-acupuncture on personality traits in depression: a randomized controlled study. Chinese journal of integrative medicine, 2013, Volume: 19, Issue:10 Topics: Case-Control Studies; Demography; Depression; Electroacupuncture; Female; Humans; Male; Middle Aged; Paroxetine; Patient Dropouts; Personality; Personality Inventory; Psychiatric Status Rating Scales	2013
Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine. The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:6 Topics: Administration, Oral; Adult; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Germany; Humans; Lavandula; Male; Middle Aged; Oils, Volatile; Paroxetine; Plant Oils; Psychiatric Status Rating Scales; Quality of Life; Remission Induction; Treatment Outcome	2014
Gains in employment status following antidepressant medication or cognitive therapy for depression. The British journal of psychiatry : the journal of mental science, 2015, Volume: 206, Issue:4 Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Depression; Depressive Disorder, Major; Employment; Follow-Up Studies; Humans; Odds Ratio; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2015
Trajectories of recovery in depressed Parkinson's disease patients treated with paroxetine or venlafaxine. Parkinsonism & related disorders, 2016, Volume: 23 Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Paroxetine; Venlafaxine Hydrochloride	2016
Comparative Efficacy of Newer Antidepressants in Combination with Pregabalin for Fibromyalgia Syndrome: A Controlled, Randomized Study. Pain practice : the official journal of World Institute of Pain, 2017, Volume: 17, Issue:1 Topics: Adult; Amitriptyline; Antidepressive Agents; Depression; Drug Therapy, Combination; Female; Fibromyalgia; Humans; Male; Middle Aged; Paroxetine; Pregabalin; Quality of Life; Venlafaxine Hydrochloride	2017
Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss. World journal of gastroenterology, 2016, Jun-14, Volume: 22, Issue:22 Topics: Adiposity; Adult; Affect; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Checklist; China; Depression; Dyspepsia; Female; Hormones; Humans; Intra-Abdominal Fat; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome; Weight Loss	2016
Comparison of paroxetine and amitriptyline in the treatment of refractory globus pharyngeus. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:9 Topics: Adult; Amitriptyline; Antidepressive Agents; Anxiety; China; Depression; Double-Blind Method; Female; Humans; Lansoprazole; Male; Middle Aged; Paroxetine; Pharyngeal Diseases; Prospective Studies; Proton Pump Inhibitors; Psychiatric Status Rating Scales; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome	2016
Changes in circulating cytokine levels in midlife women with psychological symptoms with selective serotonin reuptake inhibitor and Japanese traditional medicine. Maturitas, 2009, Feb-20, Volume: 62, Issue:2 Topics: Administration, Oral; Climacteric; Cytokines; Depression; Drugs, Chinese Herbal; Hot Flashes; Humans; Magnoliopsida; Medicine, East Asian Traditional; Middle Aged; Paroxetine; Phytotherapy; Plant Extracts; Selective Serotonin Reuptake Inhibitors	2009
Superiority of escitalopram to paroxetine in the treatment of depression. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2009, Volume: 19, Issue:4 Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Citalopram; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paroxetine; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome	2009
The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Jul-15, Volume: 24, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depression; Disability Evaluation; Double-Blind Method; Female; Humans; Male; Middle Aged; Nortriptyline; Parkinson Disease; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Recurrence; Treatment Outcome	2009
FKBP5 polymorphisms and antidepressant response in geriatric depression. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 2010, Mar-05, Volume: 153B, Issue:2 Topics: Aged; Antidepressive Agents; Depression; Double-Blind Method; Female; Genetic Variation; Geriatrics; Humans; Male; Mianserin; Mirtazapine; Paroxetine; Polymorphism, Genetic; Sequence Analysis, DNA; Tacrolimus Binding Proteins; Treatment Outcome	2010
Effect of cytochrome P450 2D6 genotype on maternal paroxetine plasma concentrations during pregnancy. Clinical pharmacokinetics, 2009, Volume: 48, Issue:10 Topics: Adult; Antidepressive Agents, Second-Generation; Cohort Studies; Cytochrome P-450 CYP2D6; Depression; Drug Monitoring; Female; Genotype; Humans; Middle Aged; Paroxetine; Pharmacogenetics; Pregnancy; Surveys and Questionnaires; Treatment Outcome; Young Adult	2009
Gepirone-ER treatment of low sexual desire associated with depression in women as measured by the DeRogatis Inventory of Sexual Function (DISF) fantasy/cognition (desire) domain--a post hoc analysis. The journal of sexual medicine, 2011, Volume: 8, Issue:9 Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Delayed-Action Preparations; Depression; Double-Blind Method; Female; Humans; Libido; Paroxetine; Psychiatric Status Rating Scales; Psychological Tests; Pyrimidines; Sexual Dysfunctions, Psychological; Treatment Outcome	2011
The influence of personality factors on paroxetine response time in patients with major depression. Journal of affective disorders, 2011, Volume: 135, Issue:1-3 Topics: Adult; Aged; Antidepressive Agents; Character; Depression; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Paroxetine; Personality; Personality Disorders; Personality Inventory; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Temperament; Treatment Outcome	2011
Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Sleep medicine, 2012, Volume: 13, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Treatment Outcome; Young Adult	2012
Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity? Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Biomarkers; Body Mass Index; Cyclohexanols; Depression; Female; Humans; Leptin; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Time Factors; Treatment Outcome; Up-Regulation; Venlafaxine Hydrochloride; Weight Gain; Young Adult	2013
[Effects of apolipoprotein E genetic polymorphism on susceptibility of depression and efficacy of antidepressants]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2012, Volume: 34, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Apolipoproteins E; Cyclohexanols; Depression; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2012
5-HTTLPR rs25531A > G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:1 Topics: Analysis of Variance; Antidepressive Agents; Depression; Female; Fluvoxamine; Gene Frequency; Genotype; Humans; Japan; Logistic Models; Male; Paroxetine; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Serotonin Plasma Membrane Transport Proteins; Time Factors; Treatment Outcome	2013
[Global improvement in agitated depression treated with the alliance therapy of acupuncture and seroxat and the observation of the quality of life]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2012, Volume: 32, Issue:12 Topics: Acupuncture Therapy; Adolescent; Adult; Antidepressive Agents; Combined Modality Therapy; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Quality of Life; Young Adult	2012
Platelet serotonin transporter in stroke patients. Acta neurologica Scandinavica, 2003, Volume: 107, Issue:2 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Binding, Competitive; Biomarkers; Blood Platelets; Carrier Proteins; Chronic Disease; Depression; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Reference Values; Serotonin Plasma Membrane Transport Proteins; Stroke; Time Factors	2003
Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety. JPMA. The Journal of the Pakistan Medical Association, 2002, Volume: 52, Issue:11 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome	2002
Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial. BMC family practice, 2003, May-14, Volume: 4 Topics: Adult; Antidepressive Agents, Second-Generation; Blood Glucose; Depression; Diabetes Mellitus, Type 2; Female; Humans; Middle Aged; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Single-Blind Method	2003
Paroxetine-induced conversion of cytochrome P450 2D6 phenotype and occurence of adverse effects. General physiology and biophysics, 2003, Volume: 22, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP2D6; Depression; Female; Genotype; Humans; Male; Middle Aged; Paroxetine; Phenotype; Sexual Dysfunctions, Psychological; Treatment Outcome	2003
The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients. Biological psychiatry, 2003, Oct-01, Volume: 54, Issue:7 Topics: Aged; Aged, 80 and over; Alleles; Antidepressive Agents; Apolipoproteins E; Chromatography, High Pressure Liquid; Cognition; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Genotype; Geriatric Psychiatry; Humans; Male; Mianserin; Mirtazapine; Neuropsychological Tests; Paroxetine; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome	2003
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biological psychiatry, 2003, Nov-01, Volume: 54, Issue:9 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Depression; Double-Blind Method; Female; Humans; Interferon-alpha; Kynurenine; Male; Melanoma; Middle Aged; Neopterin; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Tryptophan	2003
The Kutcher Adolescent Depression Scale: assessment of its evaluative properties over the course of an 8-week pediatric pharmacotherapy trial. Journal of child and adolescent psychopharmacology, 2003,Fall, Volume: 13, Issue:3 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Depression; Double-Blind Method; Female; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Reproducibility of Results	2003
Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Dec-15, Volume: 21, Issue:24 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Chi-Square Distribution; Depression; Double-Blind Method; Fatigue; Female; Humans; Male; Middle Aged; Neoplasms; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2003
Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age. Human psychopharmacology, 2004, Volume: 19, Issue:6 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Chi-Square Distribution; Cohort Studies; Cyclopropanes; Depression; Female; Fluvoxamine; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2004
Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder. Psychopharmacology, 2004, Volume: 176, Issue:3-4 Topics: Adult; Affect; Agoraphobia; Citalopram; Cognition; Cross-Sectional Studies; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2004
Treatment of depression and effect of antidepression treatment on nutritional status in chronic hemodialysis patients. The American journal of the medical sciences, 2005, Volume: 329, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Status; Paroxetine; Renal Dialysis	2005
Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast cancer research and treatment, 2005, Volume: 89, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Breast Neoplasms; Depression; Double-Blind Method; Fatigue; Female; Humans; Male; Middle Aged; Paroxetine; Placebos; Treatment Outcome	2005
Paroxetine serum concentrations in depressed patients and response to treatment. Pharmacopsychiatry, 2005, Volume: 38, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Depression; Dose-Response Relationship, Drug; Electrochemistry; Female; Humans; Male; Middle Aged; Paroxetine; Severity of Illness Index; Time Factors; Treatment Outcome	2005
Selective serotonin reuptake inhibitors treatment effects on auditory measures in depressed female subjects. European journal of pharmacology, 2005, Sep-27, Volume: 520, Issue:1-3 Topics: Acoustic Impedance Tests; Adult; Brain; Depression; Dichotic Listening Tests; Evoked Potentials, Auditory, Brain Stem; Female; Fluoxetine; Humans; Loudness Perception; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Speech Perception	2005
[Comparative efficacy and tolerability of paroxetine and amitriptiline in long-term therapy preventing depressive recurrences]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2005, Volume: 105, Issue:10 Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Data Interpretation, Statistical; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Quality of Life; Recurrence; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome	2005
Risperidone in the treatment of psychotic depression. Progress in neuro-psychopharmacology & biological psychiatry, 2006, Volume: 30, Issue:4 Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antipsychotic Agents; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Time Factors	2006
Paroxetine treatment of compulsive hoarding. Journal of psychiatric research, 2007, Volume: 41, Issue:6 Topics: Adult; Anxiety; Compulsive Behavior; Depression; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires	2007
Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome. CNS drugs, 2006, Volume: 20, Issue:8 Topics: Adult; Age Factors; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Depression; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Retrospective Studies; Sex Factors; Substance Withdrawal Syndrome	2006
Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study. Pharmacopsychiatry, 2006, Volume: 39, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Female; Humans; Hypericum; Male; Middle Aged; Paroxetine; Plant Extracts; Psychiatric Status Rating Scales; Secondary Prevention; Treatment Outcome	2006
[Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up]. Orvosi hetilap, 2006, Dec-17, Volume: 147, Issue:50 Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Depression; Female; Follow-Up Studies; Humans; Hungary; Male; Middle Aged; Paroxetine; Prevalence; Quality of Life; Selective Serotonin Reuptake Inhibitors; Stroke; Time Factors; Treatment Outcome	2006
Time course of response to paroxetine: influence of plasma level. Progress in neuro-psychopharmacology & biological psychiatry, 2007, May-09, Volume: 31, Issue:4 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Time Factors	2007
A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure. American heart journal, 2007, Volume: 153, Issue:5 Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Delayed-Action Preparations; Depression; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Quality of Life; Treatment Outcome	2007
Determination of the antidepressant paroxetine and its three main metabolites in human plasma by liquid chromatography with fluorescence detection. Analytica chimica acta, 2007, May-22, Volume: 591, Issue:2 Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Depression; Fluorescence; Humans; Paroxetine; Reproducibility of Results	2007
Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial. BMC family practice, 2007, Jun-15, Volume: 8 Topics: Aged; Antidepressive Agents, Second-Generation; Blood Glucose; Depression; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Health Status Indicators; Humans; Male; Mental Health; Middle Aged; Paroxetine; Quality of Life	2007
Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. Journal of the American Geriatrics Society, 2007, Volume: 55, Issue:9 Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Follow-Up Studies; Humans; Interpersonal Relations; Male; Paroxetine; Psychotherapy, Brief; Quality of Life; Recurrence; Retrospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome	2007
[Effects of paroxetine with or without zolpidem on depression with insomnia: a multi-center randomized comparative study]. Zhonghua yi xue za zhi, 2007, Jun-19, Volume: 87, Issue:23 Topics: Antidepressive Agents, Second-Generation; Depression; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Male; Outcome Assessment, Health Care; Paroxetine; Pyridines; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Zolpidem	2007
Clinical observation on treatment of depression by electro-acupuncture combined with Paroxetine. Chinese journal of integrative medicine, 2007, Volume: 13, Issue:3 Topics: Adult; Combined Modality Therapy; Depression; Electroacupuncture; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2007
A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression. International clinical psychopharmacology, 2007, Volume: 22, Issue:6 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dizziness; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Nausea; Paroxetine; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia	2007
Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI). European journal of clinical pharmacology, 2008, Volume: 64, Issue:3 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Area Under Curve; Bradycardia; Cytochrome P-450 CYP2D6; Depression; Dose-Response Relationship, Drug; Drug Interactions; Female; Genotype; Heart Rate; Humans; Hypotension, Orthostatic; Male; Metoprolol; Middle Aged; Myocardial Infarction; Paroxetine	2008
Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2008, Volume: 18, Issue:2 Topics: Adult; Depression; Double-Blind Method; Drug Evaluation; Drug Synergism; Female; Humans; Inpatients; Male; Middle Aged; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Statistics, Nonparametric; Time Factors	2008
Paroxetine versus placebo for women in midlife after hormone therapy discontinuation. The American journal of medicine, 2008, Volume: 121, Issue:2 Topics: Adult; Depression; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome	2008
Paroxetine in the treatment of post traumatic stress disorder: our experiences. Bosnian journal of basic medical sciences, 2008, Volume: 8, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Dose-Response Relationship, Drug; Health Surveys; Humans; Outcome Assessment, Health Care; Paranoid Disorders; Paroxetine; Phobic Disorders; Stress Disorders, Post-Traumatic; Treatment Outcome	2008
Clinical trials of antidepressants: the hidden face: where locus of control appears to play a key role in depression outcome. Psychopharmacology, 1995, Volume: 119, Issue:4 Topics: Adult; Antidepressive Agents; Depression; Fluoxetine; Humans; Internal-External Control; Maprotiline; Paroxetine; Psychiatric Status Rating Scales; Time Factors; Treatment Outcome	1995
Assessment of paroxetine-induced sexual dysfunction using the Changes in Sexual Functioning Questionnaire. Psychopharmacology bulletin, 1995, Volume: 31, Issue:2 Topics: Adult; Depression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Self-Assessment; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Time Factors	1995
Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients. Psychopharmacology, 1995, Volume: 119, Issue:3 Topics: Aged; Aging; Amitriptyline; Depression; Double-Blind Method; Female; Humans; Male; Paroxetine; Time Factors	1995
Paroxetine in the treatment of Chinese patients with depressive episode: a double-blind randomized comparison with imipramine. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1996, Volume: 57, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depression; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	1996
Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. The American journal of psychiatry, 1998, Volume: 155, Issue:4 Topics: Adult; Anger; Depression; Double-Blind Method; Female; Humans; Male; Mental Disorders; Paroxetine; Patient Dropouts; Personality Disorders; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention; Suicide, Attempted; Treatment Outcome	1998
Antidepressants augment natural killer cell activity: in vivo and in vitro. Neuropsychobiology, 1999, Volume: 39, Issue:1 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Fluoxetine; Humans; Immunoassay; In Vitro Techniques; Killer Cells, Natural; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Stimulation, Chemical	1999
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:1 Topics: Adult; Aged; Anxiety; Breast Neoplasms; Confidence Intervals; Depression; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Pilot Projects; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Surveys and Questionnaires; Survivors	2000
Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults. JAMA, 2000, Sep-27, Volume: 284, Issue:12 Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Dysthymic Disorder; Family Practice; Female; Humans; Male; Paroxetine; Psychological Tests; Psychotherapy; Treatment Outcome	2000
Tolerability of paroxetine in Parkinson's disease: a prospective study. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:5 Topics: Aged; Antiparkinson Agents; Clinical Protocols; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Parkinson Disease; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2000
Nicotine patch and paroxetine for smoking cessation. Journal of consulting and clinical psychology, 2000, Volume: 68, Issue:5 Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Paroxetine; Patient Compliance; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome	2000
Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study. The Journal of rheumatology, 2000, Volume: 27, Issue:12 Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Arthritis, Rheumatoid; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Treatment Outcome	2000
Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:3 Topics: Adult; Ambulatory Care; Depression; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Stress Disorders, Post-Traumatic; Treatment Outcome; Triiodothyronine	2001
Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. The Journal of family practice, 2001, Volume: 50, Issue:5 Topics: Adolescent; Adult; Antidepressive Agents; Depression; Double-Blind Method; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Primary Health Care; Problem Solving; Psychiatric Status Rating Scales; Psychotherapy; Remission Induction; Severity of Illness Index; Treatment Outcome	2001
Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms. Journal of traumatic stress, 2001, Volume: 14, Issue:3 Topics: Adult; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride	2001
Adjunctive osteopathic manipulative treatment in women with depression: a pilot study. The Journal of the American Osteopathic Association, 2001, Volume: 101, Issue:9 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Female; Humans; Manipulation, Orthopedic; Middle Aged; Osteopathic Medicine; Paroxetine; Physical Examination; Pilot Projects; Prospective Studies; Psychometrics; Psychotherapy; Treatment Outcome	2001
A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2001,Fall, Volume: 9, Issue:4 Topics: Aged; Alzheimer Disease; Antidepressive Agents, Tricyclic; Depression; Double-Blind Method; Female; Humans; Male; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors	2001
Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast cancer research and treatment, 2001, Volume: 70, Issue:1 Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Breast Neoplasms; Depression; Double-Blind Method; Female; Humans; Middle Aged; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Time Factors; Treatment Outcome	2001
Credibility of problem-solving therapy and medication for the treatment of depression among primary care patients. Medical science monitor : international medical journal of experimental and clinical research, 2002, Volume: 8, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Depression; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Psychotherapeutic Processes; Time Factors; Treatment Outcome	2002
A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. Journal of pain and symptom management, 2002, Volume: 23, Issue:4 Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Depression; Fatigue; Female; Hot Flashes; Humans; Middle Aged; Paroxetine; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders	2002
Response styles among patients with minor depression and dysthymia in primary care. Journal of abnormal psychology, 2002, Volume: 111, Issue:2 Topics: Adolescent; Adult; Cognitive Behavioral Therapy; Depression; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Primary Health Care; Problem Solving; Treatment Outcome	2002
The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain, 1990, Volume: 42, Issue:2 Topics: Depression; Desipramine; Diabetic Neuropathies; Humans; Imipramine; Nervous System; Osmolar Concentration; Paroxetine; Piperidines; Serotonin Antagonists; Time Factors	1990

Other Studies

218 other study(ies) available for paroxetine and Depression

Article	Year
A combination of P300 and eye movement data improves the accuracy of auxiliary diagnoses of depression. Journal of affective disorders, 2022, 01-15, Volume: 297 Topics: Depression; Eye Movements; Humans; Paroxetine; Transcranial Magnetic Stimulation; Treatment Outcome	2022
The network analysis of depressive symptoms before and after two weeks of antidepressant treatment. Journal of affective disorders, 2022, 02-15, Volume: 299 Topics: Antidepressive Agents; Depression; Depressive Disorder, Major; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2022
Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors. JAMA network open, 2022, 02-01, Volume: 5, Issue:2 Topics: Adult; Aged; Analgesics, Opioid; Cohort Studies; Comorbidity; Depression; Emergency Medical Services; Female; Fluoxetine; Hospitalization; Humans; Male; Middle Aged; Opiate Overdose; Oxycodone; Pain; Paroxetine; Selective Serotonin Reuptake Inhibitors	2022
Effects of Paroxetine on Plasma Levels of Vascular Endothelial Growth Factor in Patients with Major Depression. Psychiatria Danubina, 2022,Fall, Volume: 34, Issue:3 Topics: Depression; Depressive Disorder, Major; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Vascular Endothelial Growth Factor A	2022
Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine. Frontiers in immunology, 2023, Volume: 14 Topics: Anti-Inflammatory Agents; Antidepressive Agents; Depression; Humans; Inflammation; Inflammatory Bowel Diseases; Paroxetine; Tumor Necrosis Factor Inhibitors	2023
Estimating the prevalence of depression using wastewater-based epidemiology: A case study in Qinghai Province, West China. The Science of the total environment, 2023, Jul-15, Volume: 882 Topics: Antidepressive Agents; China; Depression; Paroxetine; Prevalence; Sertraline; Venlafaxine Hydrochloride; Wastewater; Water Pollutants, Chemical	2023
The antidepressant-like effects of escitalopram in mice require salt-inducible kinase 1 and CREB-regulated transcription co-activator 1 in the paraventricular nucleus of the hypothalamus. Journal of affective disorders, 2023, 10-01, Volume: 338 Topics: Animals; Antidepressive Agents; Depression; Escitalopram; Fluoxetine; Humans; Mice; Paraventricular Hypothalamic Nucleus; Paroxetine; Serotonin; Stress, Psychological	2023
A new method for analyzing clinical trials in depression based on individual propensity to respond to placebo estimated using artificial intelligence. Psychiatry research, 2023, Volume: 327 Topics: Artificial Intelligence; Depression; Depressive Disorder, Major; Humans; Paroxetine; Randomized Controlled Trials as Topic	2023
Basal Ganglia Calcification: A Case Report of Fahr Disease With Pure Psychiatric Symptoms. Journal of psychiatric practice, 2019, Volume: 25, Issue:5 Topics: Basal Ganglia; Basal Ganglia Diseases; Calcinosis; Depression; Diagnosis, Differential; Female; Humans; Mental Disorders; Middle Aged; Neurodegenerative Diseases; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Psychotropic Drugs; Tomography, X-Ray Computed; Treatment Outcome	2019
Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder. Psychiatric genetics, 2020, Volume: 30, Issue:1 Topics: Adult; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Pharmacological; Depression; Depressive Disorder, Major; Female; Genotype; Humans; Male; Middle Aged; Paroxetine; Pharmacogenetics; Polymorphism, Single Nucleotide; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins	2020
A novel stress re-stress model: modification of re-stressor cue induces long-lasting post-traumatic stress disorder-like symptoms in rats. The International journal of neuroscience, 2020, Volume: 130, Issue:9 Topics: Animals; Anxiety; Behavior, Animal; Cognitive Dysfunction; Corticosterone; Cues; Depression; Disease Models, Animal; Electric Stimulation; Hypothalamo-Hypophyseal System; Male; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic	2020
Combination of mirtazapine and paroxetine: possible clinically demonstrated interaction? Casopis lekaru ceskych, 2019,Winter, Volume: 158, Issue:7-8 Topics: Antidepressive Agents; Cytochrome P-450 Enzyme System; Depression; Drug Interactions; Humans; Mirtazapine; Paroxetine	2019
Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication. Journal of the American Geriatrics Society, 2020, Volume: 68, Issue:7 Topics: Aged; Antidepressive Agents; Depression; Female; Fractures, Bone; Humans; Male; North America; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Taiwan; United Kingdom; Venlafaxine Hydrochloride	2020
Antidepressant action of transcranial direct current stimulation in olfactory bulbectomised adolescent rats. Journal of psychopharmacology (Oxford, England), 2021, Volume: 35, Issue:8 Topics: Animals; Brain-Derived Neurotrophic Factor; Combined Modality Therapy; Depression; Disease Models, Animal; Male; Olfactory Bulb; Paroxetine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Transcranial Direct Current Stimulation	2021
BiteStrip analysis of the effect of fluoxetine and paroxetine on sleep bruxism. Archives of oral biology, 2017, Volume: 80 Topics: Adult; Anxiety; Dental Devices, Home Care; Depression; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Bruxism; Treatment Outcome	2017
Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis. BMJ open, 2017, Aug-03, Volume: 7, Issue:8 Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder; Doxepin; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Paroxetine; Patient Acceptance of Health Care; Reboxetine; Selective Serotonin Reuptake Inhibitors; Stroke; Treatment Outcome	2017
Mouse strain differences in SSRI sensitivity correlate with serotonin transporter binding and function. Scientific reports, 2017, 08-17, Volume: 7, Issue:1 Topics: Animals; Citalopram; Depression; Fluoxetine; Hindlimb Suspension; Male; Mice, Inbred C57BL; Mice, Inbred DBA; Paroxetine; Protein Binding; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Species Specificity; Swimming; Synaptosomes	2017
Depressive symptoms, monoamines levels, MAO-B activity and effect of treatment in a subset of depressed individuals from government sector hospital at Karachi. Pakistan journal of pharmaceutical sciences, 2017, Volume: 30, Issue:4(Suppl.) Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Case-Control Studies; Depression; Female; Fluoxetine; Homovanillic Acid; Hospitals, Public; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Monoamine Oxidase; Pakistan; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Suicidal Ideation; Treatment Outcome; Young Adult	2017
Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder. Psychoneuroendocrinology, 2018, Volume: 87 Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Case-Control Studies; China; Cytokines; Depression; Depressive Disorder, Major; Female; Humans; Interleukin-1beta; Interleukin-6; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride	2018
Paroxetine blunts the corticosterone response to swim-induced stress and increases depressive-like behavior in a rat model of postpartum depression. Psychoneuroendocrinology, 2018, Volume: 89 Topics: Animals; Corticosterone; Depression; Depression, Postpartum; Disease Models, Animal; Female; Male; Paroxetine; Peripartum Period; Postpartum Period; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological; Swimming	2018
[Exploring the clinical characters of Shugan Jieyu capsule through text mining]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2017, Volume: 42, Issue:17 Topics: Anxiety; Data Mining; Depression; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fluoxetine; Humans; Paroxetine; Sertraline	2017
Does G2677T Polymorphism of the MDR1 Gene Make a Difference in the Therapeutic Response to Paroxetine in Depressed Patients in a Slovakian Population? Medical science monitor : international medical journal of experimental and clinical research, 2018, May-13, Volume: 24 Topics: Adult; Alleles; ATP Binding Cassette Transporter, Subfamily B; Depression; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Paroxetine; Polymorphism, Single Nucleotide; Slovakia; Treatment Outcome	2018
MicroRNA-451a, microRNA-34a-5p, and microRNA-221-3p as predictors of response to antidepressant treatment. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2018, Volume: 51, Issue:7 Topics: Adult; Antidepressive Agents, Second-Generation; Biomarkers; Case-Control Studies; Depression; Educational Status; Female; Gene Expression Profiling; Humans; Male; MicroRNAs; Paroxetine; Psychiatric Status Rating Scales; Real-Time Polymerase Chain Reaction; Suicidal Ideation; Treatment Outcome	2018
Effectiveness of paroxetine in the treatment of poststroke depression. Medicine, 2018, Volume: 97, Issue:29 Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Retrospective Studies; Stroke; Treatment Outcome	2018
Alleviating Effect of Antidepressant Treatment on Psychiatric Symptoms and Cardiac Conditions in a Patient with Coronary Slow Flow Comorbid with Depression and Anxiety. The American journal of case reports, 2018, Sep-06, Volume: 19 Topics: Antidepressive Agents; Anxiety; Comorbidity; Depression; Female; Humans; Middle Aged; Myocardial Infarction; Paroxetine	2018
Cumulative Antidepressant Use and Risk of Dementia in a Prospective Cohort Study. Journal of the American Geriatrics Society, 2018, Volume: 66, Issue:10 Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cholinergic Antagonists; Dementia; Depression; Female; Humans; Independent Living; Male; Paroxetine; Proportional Hazards Models; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors; Washington	2018
Perinatal exposure to the SSRI paroxetine alters the methylome landscape of the developing dentate gyrus. The European journal of neuroscience, 2019, Volume: 50, Issue:2 Topics: Animals; Animals, Newborn; Antidepressive Agents; Behavior, Animal; Dentate Gyrus; Depression; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Female; Gene Expression; Male; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Selective Serotonin Reuptake Inhibitors; Sex Factors	2019
Pharmacologic chaos: severe hypotension from interactions of anesthetics, marijuana, amphetamines, and paroxetine. Journal of clinical anesthesia, 2019, Volume: 55 Topics: Adolescent; Amphetamines; Anesthesia; Anesthetics, Inhalation; Cannabis; Depression; Drug Interactions; Female; Humans; Hypotension; Marijuana Smoking; Pain, Postoperative; Paroxetine; Spinal Fusion; Substance Abuse Detection	2019
Selective Serotonin Reuptake Inhibitors Aggravate Depression-Associated Dry Eye Via Activating the NF-κB Pathway. Investigative ophthalmology & visual science, 2019, 01-02, Volume: 60, Issue:1 Topics: Animals; Blotting, Western; Cells, Cultured; Cytokines; Depression; Dry Eye Syndromes; Enzyme-Linked Immunosorbent Assay; Epithelium, Corneal; Flow Cytometry; Humans; Immunohistochemistry; Male; NF-kappa B; Paroxetine; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Selective Serotonin Reuptake Inhibitors; Serotonin; Tears	2019
Paroxetine Psychopharmacology bulletin, 2019, 02-15, Volume: 49, Issue:1 Topics: Antidepressive Agents; Depression; Double-Blind Method; Female; Humans; Middle Aged; Paroxetine; Postmenopause; Psychiatric Status Rating Scales; Retrospective Studies; Vortioxetine	2019
Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis. The lancet. Psychiatry, 2019, Volume: 6, Issue:9 Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depression; Depressive Disorder, Major; Fluoxetine; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Paroxetine; Placebos; Psychiatric Status Rating Scales; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index	2019
Influence of body mass index on the choice of therapy for depression and follow-up care. Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Body Mass Index; Choice Behavior; Cohort Studies; Depression; Female; Fluoxetine; Follow-Up Studies; Humans; Logistic Models; Male; Mianserin; Middle Aged; Mirtazapine; Obesity; Paroxetine; Psychotherapy; Young Adult	2013
Antidepressant- and anticompulsive-like effects of purinergic receptor blockade: involvement of nitric oxide. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:12 Topics: Animals; Antidepressive Agents; Brain; Compulsive Behavior; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Hippocampus; Immobility Response, Tonic; Male; Maze Learning; Nitric Oxide; Nitric Oxide Synthase Type II; Paroxetine; Purinergic Antagonists; Pyridoxal Phosphate; Rats; Receptors, Purinergic; Swimming	2013
Anti-depressant like activity of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) a 5-HT3 receptor antagonist. Indian journal of experimental biology, 2013, Volume: 51, Issue:6 Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Depression; Fluoxetine; Guinea Pigs; Mice; Motor Activity; Olfactory Bulb; Paroxetine; Quinoxalines; Rats; Rats, Wistar; Serotonin 5-HT3 Receptor Antagonists; Swimming	2013
Antidepressants and testicular cancer. Cancer causes & control : CCC, 2014, Volume: 25, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; California; Case-Control Studies; Cohort Studies; Depression; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Testicular Neoplasms; Young Adult	2014
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. Parkinsonism & related disorders, 2014, Volume: 20, Issue:6 Topics: Aged; Antidepressive Agents; Anxiety; Cyclohexanols; Datasets as Topic; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Paroxetine; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Venlafaxine Hydrochloride	2014
Dietary magnesium restriction reduces amygdala-hypothalamic GluN1 receptor complex levels in mice. Brain structure & function, 2015, Volume: 220, Issue:4 Topics: Amygdala; Analysis of Variance; Animals; Depression; Diet; Disease Models, Animal; Gene Expression Regulation; Hypothalamus; Magnesium; Magnesium Deficiency; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Paroxetine; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors	2015
Co-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure. Acta pharmacologica Sinica, 2014, Volume: 35, Issue:6 Topics: Animals; Anticholesteremic Agents; Antidepressive Agents, Second-Generation; Blood Glucose; Cell Line; Depression; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Drug Interactions; Hypercholesterolemia; Insulin; Male; Paroxetine; Pravastatin; Rats; Rats, Sprague-Dawley; Serotonin	2014
Stimulation of Sigma-1 Receptor Ameliorates Depressive-like Behaviors in CaMKIV Null Mice. Molecular neurobiology, 2015, Volume: 52, Issue:3 Topics: Adenosine Triphosphate; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; CA3 Region, Hippocampal; Calbindins; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Dentate Gyrus; Depression; Fluvoxamine; Gene Expression Regulation; Immobilization; Long-Term Potentiation; Male; Maze Learning; Mice; Mice, Knockout; Nerve Tissue Proteins; Neurogenesis; Paroxetine; Phosphorylation; Piperazines; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Sigma-1 Receptor	2015
Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans. PLoS medicine, 2014, Volume: 11, Issue:11 Topics: Adult; Amitriptyline; Animals; Antidepressive Agents; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Blood Cells; Depression; Depressive Disorder; Female; Humans; Leukocytes, Mononuclear; Male; Membrane Proteins; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Paroxetine; Rats, Sprague-Dawley; Stress, Psychological; Tacrolimus Binding Proteins; Young Adult	2014
A 5-HT3 receptor antagonist potentiates the behavioral, neurochemical and electrophysiological actions of an SSRI antidepressant. Pharmacology, biochemistry, and behavior, 2015, Volume: 131 Topics: Animals; Depression; Disease Models, Animal; Dorsal Raphe Nucleus; Drug Synergism; Electrophysiological Phenomena; Hippocampus; Male; Microdialysis; Ondansetron; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT3 Receptor Antagonists	2015
FKBP5/FKBP51 enhances autophagy to synergize with antidepressant action. Autophagy, 2015, Volume: 11, Issue:3 Topics: Amitriptyline; Animals; Antidepressive Agents; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Behavior, Animal; Depression; Electrophysiology; Gene Expression Regulation; HSP90 Heat-Shock Proteins; Humans; Immunoprecipitation; Membrane Proteins; Mice; Molecular Chaperones; Paroxetine; Phosphorylation; Tacrolimus Binding Proteins	2015
Antidepressant treatment decreases daily salt intake and prevents heart dysfunction following subchronic aortic regurgitation in rats. Physiology & behavior, 2015, May-15, Volume: 144 Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Aortic Valve Insufficiency; Blood Pressure; Depression; Disease Models, Animal; Drinking; Echocardiography; Heart Rate; Male; Myocardium; Organ Size; Paroxetine; Potassium; Rats; Rats, Wistar; Sodium Chloride; Time Factors; Water-Electrolyte Balance	2015
Clinical presentation and pharmacotherapy response in social anxiety disorder: The effect of etiological beliefs. Psychiatry research, 2015, Jul-30, Volume: 228, Issue:1 Topics: Adolescent; Adult; Anxiety; Depression; Emotions; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Paroxetine; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult	2015
Effects of amycenone on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration. Pharmacology, biochemistry, and behavior, 2015, Volume: 136 Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Interleukin-10; Lipopolysaccharides; Male; Mice; Paroxetine; Plant Extracts; Tumor Necrosis Factor-alpha	2015
Paroxetine-Related Adult-Onset Tic Disorder: A Presentation of Primary Progressive Multiple Sclerosis. The Journal of neuropsychiatry and clinical neurosciences, 2015,Summer, Volume: 27, Issue:3 Topics: Antidepressive Agents, Second-Generation; Brain; Depression; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Multiple Sclerosis, Chronic Progressive; Paroxetine; Tic Disorders	2015
Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning. Psychiatric services (Washington, D.C.), 2016, Volume: 67, Issue:3 Topics: Adolescent; Adult; Antidepressive Agents; Child; Child, Preschool; Citalopram; Cohort Studies; Databases, Factual; Depression; Dose-Response Relationship, Drug; Drug Labeling; Drug Prescriptions; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Practice Guidelines as Topic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Suicide, Attempted; United States; United States Food and Drug Administration; Young Adult	2016
Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine. Science signaling, 2015, Nov-24, Volume: 8, Issue:404 Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depression; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; HEK293 Cells; Humans; Mice; Paroxetine; Phosphorylation; Tacrolimus Binding Proteins	2015
Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation. Nanotechnology, 2016, Jan-15, Volume: 27, Issue:2 Topics: Administration, Intranasal; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Chemistry, Pharmaceutical; Depression; Disease Models, Animal; Emulsions; Female; Male; Paroxetine; Particle Size; Rats; Rats, Wistar; Swine	2016
Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors. Journal of the National Cancer Institute, 2016, Volume: 108, Issue:3 Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cohort Studies; Depression; Female; Health Resources; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Paroxetine; Proportional Hazards Models; Survivors; Tamoxifen; United States	2016
Use of antidepressants and breast cancer recurrence. The Lancet. Oncology, 2016, Volume: 17, Issue:1 Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Depression; Female; Humans; Neoplasm Recurrence, Local; Paroxetine; Tamoxifen	2016
Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats. Bulletin of experimental biology and medicine, 2016, Volume: 160, Issue:5 Topics: Adenine; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Imipramine; Male; Motor Activity; Paroxetine; Rats; Reserpine; Sertraline; Venlafaxine Hydrochloride	2016
A novel isoquinoline compound abolishes chronic unpredictable mild stress-induced depressive-like behavior in mice. Behavioural brain research, 2016, 07-01, Volume: 307 Topics: Adrenal Glands; Animals; Antidepressive Agents; Cytokines; Depression; Disease Models, Animal; Grooming; Hindlimb Suspension; Hormones; Locomotion; Male; Mice; Paroxetine; Prefrontal Cortex; Quinolines; Serotonin; Stress, Psychological; Swimming; Synaptosomes; Tritium	2016
Ovariectomy changes the response to antidepressant drugs in tail suspension test in mice. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:12 Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Doxepin; Estrogens; Female; Hindlimb Suspension; Menopause; Mice; Mice, Inbred ICR; Ovariectomy; Paroxetine; Venlafaxine Hydrochloride	2016
Comparative risk of hip fractures in elderly nursing home patients with depression using paroxetine and other selective serotonin reuptake inhibitors. Journal of comparative effectiveness research, 2016, Volume: 5, Issue:5 Topics: Aged; Depression; Female; Hip Fractures; Humans; Male; Nursing Homes; Paroxetine; Retrospective Studies; Risk; Selective Serotonin Reuptake Inhibitors	2016
Associations Between Personality Traits and Adherence to Antidepressants Assessed Through Self-Report, Electronic Monitoring, and Pharmacy Dispensing Data: A Pilot Study. Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:5 Topics: Adult; Antidepressive Agents; Depression; Female; Humans; Male; Medication Adherence; Middle Aged; Paroxetine; Personality; Pharmaceutical Services; Pilot Projects; Self Report	2016
Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study. Breast cancer research and treatment, 2016, Volume: 159, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Depression; Female; Humans; Ontario; Paroxetine; Patient Compliance; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome	2016
Risk of Cognitive Decline Associated With Paroxetine Use in Elderly Nursing Home Patients With Depression. American journal of Alzheimer's disease and other dementias, 2016, Volume: 31, Issue:8 Topics: Aged; Cognitive Dysfunction; Depression; Female; Homes for the Aged; Humans; Male; Nursing Homes; Paroxetine; Risk; Selective Serotonin Reuptake Inhibitors	2016
Risk of Mortality in Elderly Nursing Home Patients with Depression Using Paroxetine. Pharmacotherapy, 2017, Volume: 37, Issue:3 Topics: Aged; Aged, 80 and over; Cohort Studies; Depression; Female; Follow-Up Studies; Homes for the Aged; Humans; Male; Medicare; Nursing Homes; Paroxetine; Propensity Score; Proportional Hazards Models; Retrospective Studies; Risk; Selective Serotonin Reuptake Inhibitors; United States	2017
Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels - a review of routine practice. British journal of clinical pharmacology, 2017, Volume: 83, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Cytochrome P-450 CYP2D6 Inhibitors; Depression; Drug Interactions; Female; Humans; Middle Aged; Nortriptyline; Paroxetine	2017
[Painful palate and xerostomia after using paroxetine]. Nederlands tijdschrift voor tandheelkunde, 2008, Volume: 115, Issue:5 Topics: Depression; Female; Humans; Middle Aged; Pain; Palate, Hard; Paroxetine; Selective Serotonin Reuptake Inhibitors; Xerophthalmia; Xerostomia	2008
Expert opinion: migraine, psychiatric comorbidities, and treatment. Headache, 2008, Volume: 48, Issue:6 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Migraine Disorders; Paroxetine; Severity of Illness Index; Tryptamines	2008
Do new-generation antidepressants work? Irish medical journal, 2008, Volume: 101, Issue:5 Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Fluoxetine; Humans; Paroxetine; Piperazines; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride	2008
Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology, 2008, Volume: 200, Issue:4 Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Darkness; Depression; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Light; Male; Mice; Mice, Inbred DBA; Oligonucleotide Array Sequence Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Swimming	2008
Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression. European journal of pharmacology, 2008, Sep-11, Volume: 592, Issue:1-3 Topics: Amino Acids; Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Darkness; Depression; Diazepam; Fever; Fluoxetine; Light; Male; Mice; Paroxetine; Receptors, Metabotropic Glutamate; Reinforcement Schedule; Stress, Psychological; Xanthenes	2008
[Effects of paroxetine on protein kinase PKA, PKC and CaMKII activity in different brain regions in a rat depression model]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:7 Topics: Animals; Brain; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP-Dependent Protein Kinases; Depression; Disease Models, Animal; Hippocampus; Male; Paroxetine; Protein Kinase C; Random Allocation; Rats	2008
Strain differences in paroxetine-induced reduction of immobility time in the forced swimming test in mice: role of serotonin. European journal of pharmacology, 2008, Oct-10, Volume: 594, Issue:1-3 Topics: Animals; Antidepressive Agents, Second-Generation; Brain Chemistry; Depression; Male; Melatonin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Species Specificity; Swimming; Tryptophan	2008
The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2008, Volume: 18, Issue:12 Topics: Animals; Antidepressive Agents; Aza Compounds; Behavior, Animal; Body Weight; Bridged Bicyclo Compounds, Heterocyclic; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Ejaculation; Exploratory Behavior; Male; Olfactory Bulb; Paroxetine; Rats; Rats, Sprague-Dawley; Reaction Time; Statistics, Nonparametric	2008
Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice. The international journal of neuropsychopharmacology, 2009, Volume: 12, Issue:7 Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Brain-Derived Neurotrophic Factor; Citalopram; Depression; Disease Models, Animal; Drug Synergism; Hippocampus; In Situ Hybridization; Male; Mice; Microdialysis; Microinjections; Motor Activity; Paroxetine; Receptor, trkB; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors	2009
Proteomic analysis of rat hippocampus exposed to the antidepressant paroxetine. Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:8 Topics: Animals; Antidepressive Agents, Second-Generation; Depression; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Hippocampus; Image Processing, Computer-Assisted; Male; Paroxetine; Proteins; Proteomics; Rats; Rats, Sprague-Dawley	2010
Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States. Clinical therapeutics, 2009, Volume: 31, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Databases as Topic; Depression; Drug Costs; Drug Prescriptions; Drugs, Generic; Female; Fluoxetine; Humans; Insurance, Pharmaceutical Services; Likelihood Functions; Logistic Models; Male; Medication Adherence; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Time Factors; United States	2009
Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: does risk occur with therapeutic doses? Epilepsy & behavior : E&B, 2009, Volume: 14, Issue:4 Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Electroencephalography; Epilepsy, Generalized; Humans; Male; Middle Aged; Paroxetine; Seizures; Thiophenes	2009
The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. Journal of neurochemistry, 2009, Volume: 109, Issue:5 Topics: Animals; Antidepressive Agents, Second-Generation; Autoradiography; Brain; Citalopram; Depression; Disease Models, Animal; Fenclonine; Fenfluramine; Fluorobenzenes; Freezing Reaction, Cataleptic; Male; Paroxetine; Piperidines; Protein Binding; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT4; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Swimming; Time Factors; Tritium	2009
Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study. Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:4 Topics: Adult; Aged; Antidepressive Agents; Biomarkers; Citalopram; Depression; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome	2009
Persistent genital arousal disorder (PGAD): case report of long-term symptomatic management with electroconvulsive therapy. The journal of sexual medicine, 2009, Volume: 6, Issue:10 Topics: Bipolar Disorder; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Orgasm; Paroxetine; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Substance Withdrawal Syndrome; Time Factors	2009
Paroxetine may cause increase in carcinoebmryonic antigen (CEA). European journal of clinical pharmacology, 2009, Volume: 65, Issue:12 Topics: Carcinoembryonic Antigen; Depression; Humans; Male; Middle Aged; Paroxetine	2009
Agomelatine: new drug. Adverse effects and no proven efficacy. Prescrire international, 2009, Volume: 18, Issue:104 Topics: Acetamides; Animals; Antidepressive Agents; Bias; Carcinogens; Clinical Trials as Topic; Cyclohexanols; Depression; Depressive Disorder; Double-Blind Method; Drug Approval; Europe; Fluoxetine; Humans; Hypnotics and Sedatives; Melatonin; Paroxetine; Psychiatric Status Rating Scales; Receptors, Melatonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Suicide; Treatment Outcome; Venlafaxine Hydrochloride	2009
Is the increase in LDL cholesterol induced by selective serotonin reuptake inhibitor therapy a blessing in disguise? Medical hypotheses, 2010, Volume: 74, Issue:5 Topics: Affect; Anticholesteremic Agents; Cholesterol, LDL; Depression; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2010
Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions. Pharmacoepidemiology and drug safety, 2010, Volume: 19, Issue:2 Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Child; Child, Preschool; Depression; Humans; Infant; Paroxetine; Practice Patterns, Physicians'; United States; United States Food and Drug Administration; Young Adult	2010
Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using (1)H magnetic resonance spectroscopy. Psychiatry research, 2010, Apr-30, Volume: 182, Issue:1 Topics: Aged; Analysis of Variance; Antidepressive Agents; Aspartic Acid; Brain Mapping; Case-Control Studies; Choline; Depression; Dose-Response Relationship, Drug; Female; Functional Laterality; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Paroxetine; Stroke; Thalamus; Tritium	2010
Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: Involvement of serotonergic system. Neuropharmacology, 2010, Volume: 59, Issue:3 Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Benzene Derivatives; Brain; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Freezing Reaction, Cataleptic; Hindlimb Suspension; Male; Mice; Monoamine Oxidase; Organoselenium Compounds; Paroxetine; Protein Binding; Serotonin; Serotonin Agents; Swimming; Synaptosomes; Time Factors; Tritium	2010
ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression. Pharmacogenetics and genomics, 2010, Volume: 20, Issue:8 Topics: Aged; Aging; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Depression; Female; Genotype; Humans; Japan; Male; Paroxetine; Polymorphism, Single Nucleotide; Survival Analysis; Treatment Outcome	2010
A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach. Psychopharmacology bulletin, 2010, Volume: 43, Issue:1 Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Antidepressive Agents, Second-Generation; Blood Pressure; Cross-Sectional Studies; Depression; Female; Fluoxetine; Gene Frequency; Heart Rate; Homozygote; Humans; Linear Models; Male; Paroxetine; Pharmacogenetics; Phenotype; Pilot Projects; Receptors, Adrenergic, beta-1; Retrospective Studies; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Young Adult	2010
Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence. Canadian family physician Medecin de famille canadien, 2010, Volume: 56, Issue:8 Topics: Abnormalities, Drug-Induced; Adult; Depression; Evidence-Based Medicine; Female; Heart Defects, Congenital; Humans; Meta-Analysis as Topic; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Selective Serotonin Reuptake Inhibitors; Uncertainty	2010
Differences in clinical effect and tolerance between fluvoxamine and paroxetine: a switching study in patients with depression. Human psychopharmacology, 2010, Volume: 25, Issue:7-8 Topics: Adult; Depression; Depressive Disorder; Drug Substitution; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Treatment Outcome; Young Adult	2010
Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior. Amino acids, 2011, Volume: 40, Issue:4 Topics: Amidohydrolases; Amygdala; Animals; Antidepressive Agents; Depression; Diet; Electrophoresis, Gel, Two-Dimensional; Gene Expression Profiling; Glutamate Dehydrogenase; Hypothalamus; Magnesium Deficiency; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Oxidative Stress; Paroxetine; Proteomics; Superoxide Dismutase; Tandem Mass Spectrometry; Voltage-Dependent Anion Channel 1	2011
[Paroxetine, hypothyroidism and, despite everything, inadequate antidiuretic hormone secretion]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:2 Topics: Aged, 80 and over; Depression; Female; Humans; Hyponatremia; Hypothyroidism; Inappropriate ADH Syndrome; Paroxetine; Selective Serotonin Reuptake Inhibitors; Thyroxine	2011
Efficacy of prophylactic treatment with selective serotonin reuptake inhibitors for depression after open-heart surgery. Surgery today, 2011, Volume: 41, Issue:6 Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Cardiac Surgical Procedures; Case-Control Studies; Depression; Emergencies; Female; Heart Diseases; Humans; Middle Aged; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2011
BDNF gene polymorphisms are associated with Alzheimer's disease-related depression and antidepressant response. Journal of Alzheimer's disease : JAD, 2011, Volume: 26, Issue:3 Topics: Aged; Alleles; Alzheimer Disease; Antidepressive Agents; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Depression; Female; Genotype; Humans; Linkage Disequilibrium; Male; Paroxetine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2011
Treatment of depression as part of end-of-life care. BMJ case reports, 2008, Volume: 2008 Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Carcinoma, Squamous Cell; Depression; Drug Therapy, Combination; Esophageal Neoplasms; Fatal Outcome; Female; Humans; Mianserin; Mirtazapine; Paroxetine; Terminal Care	2008
[Approximate entropy of the placebo effect in clinical trials of newer antidepressants]. Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2010, Volume: 67, Issue:4 Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depression; Fluoxetine; Humans; Paroxetine; Placebo Effect; Placebos; Severity of Illness Index; Venlafaxine Hydrochloride	2010
Sub-chronic dietary tryptophan depletion--an animal model of depression with improved face and good construct validity. Journal of psychiatric research, 2012, Volume: 46, Issue:2 Topics: Aldosterone; Analysis of Variance; Animals; Body Weight; Brain; Calcium-Binding Proteins; Catecholamines; Chromatography, High Pressure Liquid; Corticosterone; Depression; Diet; Disease Models, Animal; DNA-Binding Proteins; Kynurenic Acid; Kynurenine; Male; Nerve Tissue Proteins; Nucleobindins; Paroxetine; Protein Binding; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Swimming; Time Factors; Tritium; Tryptophan	2012
The declining use of reboxetine in years 2000 to 2006: a pharmacoepidemiological comparative study. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:2 Topics: Antidepressive Agents; Depression; Fluoxetine; Humans; Morpholines; Paroxetine; Pharmacoepidemiology; Practice Patterns, Physicians'; Publication Bias; Reboxetine; Selective Serotonin Reuptake Inhibitors	2012
[Application of antidepressant to treat patients in the department of otolaryngology]. Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70, Issue:1 Topics: Antidepressive Agents, Second-Generation; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Tinnitus	2012
Effects of diphenyl diselenide on depressive-like behavior in ovariectomized mice submitted to subchronic stress: involvement of the serotonergic system. Psychopharmacology, 2012, Volume: 222, Issue:4 Topics: Animals; Antidepressive Agents; Benzene Derivatives; Cerebral Cortex; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; Hippocampus; Immobility Response, Tonic; Menopause; Mice; Mice, Inbred Strains; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Ondansetron; Organoselenium Compounds; Ovariectomy; Pargyline; Paroxetine; Piperazines; Pyridines; Ritanserin; Serotonergic Neurons; Serotonin Antagonists; Stress, Psychological	2012
[Efficacy of adepress (paroxetine) in the treatment of depression in patients with chronic cerebral ischemia in the late recovery phase of ischemic stroke with the estimation of the velocity of passive transmembrane ion transport]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:3 Pt 2 Topics: Aged; Antidepressive Agents, Second-Generation; Brain Ischemia; Chronic Disease; Cognition; Depression; Erythrocyte Membrane; Female; Humans; Ion Transport; Lithium; Male; Middle Aged; Paroxetine; Sodium; Treatment Outcome	2012
Paroxetine and neonatal withdrawal syndrome. BMJ case reports, 2010, Apr-29, Volume: 2010 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects	2010
Differences in FKBP51 regulation following chronic social defeat stress correlate with individual stress sensitivity: influence of paroxetine treatment. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:13 Topics: Animals; Antidepressive Agents, Second-Generation; Depression; Male; Mice; Mice, Inbred C57BL; Paroxetine; Social Behavior; Stress, Psychological; Tacrolimus Binding Proteins; Treatment Outcome	2012
Ask the doctor. I have been taking an SSRI (paroxetine HCI) for many years for chronic anxiety and, at times, panic attacks. What are the side effects of the long-term use of SSRIs? Harvard health letter, 2012, Volume: 37, Issue:10 Topics: Adult; Antidepressive Agents, Second-Generation; Child; Depression; Humans; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Suicide Prevention; Young Adult	2012
Breast cancer and antidepressant use. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:9 Topics: Adult; Aged; Antidepressive Agents; Anxiety; Breast Neoplasms; Contraindications; Cytochrome P-450 CYP2D6 Inhibitors; Depression; Drug Interactions; Female; Hot Flashes; Humans; Paroxetine; Prodrugs; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen	2012
Antidepressant and anxiolytic-like effects of 4n, a novel 5-HT3 receptor antagonist using behaviour based rodent models. Indian journal of experimental biology, 2012, Volume: 50, Issue:9 Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Depression; Emotions; Mice; Olfactory Bulb; Ondansetron; Paroxetine; Photoperiod; Quinoxalines; Rats; Rats, Wistar; Reserpine; Serotonin 5-HT3 Receptor Antagonists; Swimming	2012
Evidence for the involvement of 5-HT1A receptor in the acute antidepressant-like effect of creatine in mice. Brain research bulletin, 2013, Volume: 95 Topics: Animals; Antidepressive Agents; Creatine; Depression; Depressive Disorder; Hindlimb Suspension; Humans; Mice; Paroxetine; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Antagonists	2013
[Increased perioperative blood loss during treatment with paroxetine]. Nederlands tijdschrift voor geneeskunde, 2002, Sep-21, Volume: 146, Issue:38 Topics: Antidepressive Agents, Second-Generation; Blood Loss, Surgical; Blood Platelet Disorders; Depression; Humans; Male; Middle Aged; Paroxetine; Platelet Aggregation; Selective Serotonin Reuptake Inhibitors	2002
Reputations at stake. New scientist (1971), 2002, Mar-16, Volume: 173, Issue:2334 Topics: Access to Information; Clinical Trials as Topic; Compensation and Redress; Consumer Product Safety; Depression; Disclosure; Drug Industry; Humans; Intellectual Property; Paroxetine; Publishing; United Kingdom; United States; Violence	2002
Paroxetine-associated psoriasis. The American journal of psychiatry, 2002, Volume: 159, Issue:12 Topics: Adult; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psoriasis; Selective Serotonin Reuptake Inhibitors	2002
A case of paroxetine-induced galactorrhea. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:9 Topics: Adult; Antipsychotic Agents; Anxiety; Depression; Female; Galactorrhea; Humans; Paroxetine	2002
[Neurobiology and genetics of anxiety in an animal model]. Der Nervenarzt, 2003, Volume: 74, Issue:3 Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine Vasopressin; Arousal; Corticotropin-Releasing Hormone; Depression; Dexamethasone; Disease Models, Animal; Hypothalamo-Hypophyseal System; Motor Activity; Paroxetine; Phenotype; Pituitary-Adrenal System; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Rats; Rats, Inbred Strains; Receptors, Vasopressin	2003
Implantation of a slow release corticosterone pellet induces long-term alterations in serotonergic neurochemistry in the rat brain. Journal of neuroendocrinology, 2003, Volume: 15, Issue:6 Topics: Adrenal Glands; Animals; Body Weight; Carrier Proteins; Corticosterone; Depression; Disease Models, Animal; Drug Implants; Frontal Lobe; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Organ Size; Paroxetine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time	2003
Determination of paroxetine in geriatric depression by high-performance liquid chromatography. Pharmacological research, 2003, Volume: 48, Issue:2 Topics: Age Factors; Aged; Analysis of Variance; Chromatography, High Pressure Liquid; Depression; Drug Interactions; Drug Monitoring; Female; Humans; Male; Paroxetine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity	2003
British panel bans use of antidepressant to treat children. Nature, 2003, Jun-19, Volume: 423, Issue:6942 Topics: Adolescent; Antidepressive Agents; Child; Depression; England; Humans; Legislation, Drug; Paroxetine; Suicide; United States; United States Food and Drug Administration	2003
Are SSRIs safe for children? The Medical letter on drugs and therapeutics, 2003, Jul-07, Volume: 45, Issue:1160 Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Depression; Fatigue; Humans; Nausea; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders	2003
Antidepressant-like effects in various mice strains in the tail suspension test. Behavioural brain research, 2003, Aug-14, Volume: 143, Issue:2 Topics: Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Bupropion; Citalopram; Depression; Desipramine; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Hindlimb Suspension; Imipramine; Male; Mice; Mice, Inbred Strains; Paroxetine; Selective Serotonin Reuptake Inhibitors; Species Specificity	2003
Early Alzheimer's disease. The New England journal of medicine, 2004, Jan-01, Volume: 350, Issue:1 Topics: Dementia; Depression; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2004
Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors. The American journal of the medical sciences, 2004, Volume: 327, Issue:2 Topics: Aged; Aged, 80 and over; Depression; Diuretics; Female; Humans; Hydrochlorothiazide; Hypertension; Hyponatremia; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sodium Chloride Symporter Inhibitors	2004
Drug company experts advised staff to withhold data about SSRI use in children. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2004, Mar-02, Volume: 170, Issue:5 Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Child Welfare; Clinical Trials as Topic; Data Interpretation, Statistical; Depression; Drug Industry; Humans; North America; Paroxetine; Selective Serotonin Reuptake Inhibitors; Workforce	2004
[Case of prolonged recovery from serotonin syndrome caused by paroxetine]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2003, Volume: 105, Issue:12 Topics: Amoxapine; Cytochrome P-450 CYP2D6; Depression; Diagnosis, Differential; Drug Interactions; Humans; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Serotonin Syndrome; Time Factors	2003
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 2004, May-25, Volume: 101, Issue:21 Topics: Animals; Antidepressive Agents; Citalopram; Depression; Desipramine; Dopamine beta-Hydroxylase; Droxidopa; Fluoxetine; Gene Deletion; Mice; Morpholines; Norepinephrine; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tail	2004
[Combination of serotonergic agents resulted in severe adverse effects]. Lakartidningen, 2004, Apr-29, Volume: 101, Issue:18 Topics: Antidepressive Agents, Second-Generation; Buspirone; Cytochrome P-450 CYP2D6; Depression; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Papaverine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Serotonin Syndrome; Vasodilator Agents	2004
Spitzer sues drug giant for deceiving doctors. Nature, 2004, Jun-10, Volume: 429, Issue:6992 Topics: Adolescent; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Consumer Advocacy; Contraindications; Depression; Drug Industry; Fraud; Humans; Paroxetine; Physicians; Truth Disclosure; United Kingdom; United States; United States Food and Drug Administration	2004
Neonatal complications after intrauterine exposure to SSRI antidepressants. Prescrire international, 2004, Volume: 13, Issue:71 Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; France; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Paroxetine, a selective serotonin reuptake inhibitor, reduces depressive symptoms and subjective handicaps in patients with dizziness. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2004, Volume: 25, Issue:4 Topics: Activities of Daily Living; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Depression; Dizziness; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome	2004
A question of balance. Nature, 2004, Jul-22, Volume: 430, Issue:6998 Topics: Adolescent; Adult; Antidepressive Agents; Child; Clinical Trials as Topic; Depression; Drug Industry; Humans; Licensure; Paroxetine; Patient Advocacy; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention; Truth Disclosure; United Kingdom	2004
Prevalence of induced mania in patients treated with milnacipran: a comparison with paroxetine. European psychiatry : the journal of the Association of European Psychiatrists, 2004, Volume: 19, Issue:5 Topics: Adult; Aged; Bipolar Disorder; Cohort Studies; Cyclopropanes; Depression; Female; Humans; Male; Middle Aged; Milnacipran; Paroxetine; Prevalence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires	2004
[Unfortunate title?]. Lakartidningen, 2004, Jun-24, Volume: 101, Issue:26-27 Topics: Adolescent; Child; Depression; Fluoxetine; Humans; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors	2004
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety. Consumer reports, 2004, Volume: 69, Issue:10 Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work	2004
Selective serotonin reuptake inhibitors in familial Mediterranean fever: are we treating depression or inflammation? Rheumatology international, 2005, Volume: 25, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Arthritis; Colchicine; Depression; Drug Therapy, Combination; Familial Mediterranean Fever; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2005
Differential effects of milnacipran, fluvoxamine and paroxetine for inhibited and agitated depression. European psychiatry : the journal of the Association of European Psychiatrists, 2004, Volume: 19, Issue:7 Topics: Cohort Studies; Cyclopropanes; Depression; Drug Administration Schedule; Fluvoxamine; Humans; Milnacipran; Paroxetine; Psychomotor Agitation; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires	2004
Chronoamperometry to determine differential reductions in uptake in brain synaptosomes from serotonin transporter knockout mice. Analytical chemistry, 2005, Feb-01, Volume: 77, Issue:3 Topics: Animals; Brain; Depression; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Knockout; Microelectrodes; Nerve Tissue Proteins; Neurotransmitter Agents; Oxygen; Paroxetine; Potentiometry; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stress, Psychological; Synaptosomes	2005
Hyponatremia upon resumption of paroxetine therapy. Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:3 Topics: Aged; Depression; Female; Follow-Up Studies; Humans; Hyponatremia; Infusions, Intravenous; Isotonic Solutions; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sodium; Sodium Chloride	2005
Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI). Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005, Jun-05, Volume: 820, Issue:1 Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Citalopram; Cyclohexanols; Depression; Female; Fluoxetine; Humans; Male; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride	2005
Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Pharmacotherapy, 2005, Volume: 25, Issue:5 Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Anxiety Disorders; Citalopram; Cohort Studies; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Patient Compliance; Patient Dropouts; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic	2005
Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation. European journal of clinical pharmacology, 2005, Volume: 61, Issue:4 Topics: Adult; Citalopram; Depression; Female; Fluoxetine; Humans; Male; Middle Aged; Netherlands; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors	2005
[St. John's wort in depression. The question is not whether it is effective but how do we use it]. MMW Fortschritte der Medizin, 2005, Jul-21, Volume: 147, Issue:29-30 Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depression; Humans; Hypericum; Meta-Analysis as Topic; Paroxetine; Phytotherapy; Placebos; Selective Serotonin Reuptake Inhibitors	2005
Antidepressants and suicide: a commentary on a significant contribution to this debate. Crisis, 2005, Volume: 26, Issue:2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Child; Depression; Dothiepin; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted; Time Factors; United Kingdom	2005
Efavirenz induces depressive-like behaviour, increased stress response and changes in the immune response in rats. Neuroimmunomodulation, 2005, Volume: 12, Issue:5 Topics: Alkynes; Animals; Anti-HIV Agents; Antidepressive Agents, Second-Generation; Behavior, Animal; Benzoxazines; Cyclopropanes; Cytokines; Depression; Enzyme-Linked Immunosorbent Assay; Interleukin-1; Male; Maze Learning; Oxazines; Paroxetine; Rats; Rats, Wistar; Stress, Psychological; Tumor Necrosis Factor-alpha	2005
Paroxetine-associated spontaneous sexual stimulation. International clinical psychopharmacology, 2005, Volume: 20, Issue:6 Topics: Depression; Female; Humans; Libido; Middle Aged; Orgasm; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological	2005
A mathematical model for paroxetine antidepressant effect time course and its interaction with pindolol. Journal of pharmacokinetics and pharmacodynamics, 2005, Volume: 32, Issue:5-6 Topics: Algorithms; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Models, Theoretical; Nonlinear Dynamics; Paroxetine; Pindolol; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Time Factors; Treatment Outcome	2005
Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006, Jan-11, Volume: 26, Issue:2 Topics: Animals; Antidepressive Agents; Biopterins; Brain; Chlorocebus aethiops; COS Cells; Depression; Enzyme Induction; Freezing Reaction, Cataleptic; Gene Expression Regulation, Developmental; Humans; Imipramine; Mice; Mice, Inbred Strains; Paroxetine; Raphe Nuclei; Recombinant Fusion Proteins; RNA, Messenger; Serotonin; Tryptophan; Tryptophan Hydroxylase	2006
Comparison of first refill rates among users of sertraline, paroxetine, and citalopram. Clinical therapeutics, 2006, Volume: 28, Issue:2 Topics: Adolescent; Adult; Anxiety Disorders; Citalopram; Cohort Studies; Cost Sharing; Databases, Factual; Depression; Drug Prescriptions; Female; Humans; Logistic Models; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; United States	2006
Planning and analysis of three-arm non-inferiority trials with binary endpoints. Statistics in medicine, 2007, Jan-30, Volume: 26, Issue:2 Topics: Controlled Clinical Trials as Topic; Data Interpretation, Statistical; Depression; Duloxetine Hydrochloride; Humans; Paroxetine; Research Design; Sample Size; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Therapeutic Equivalency; Thiophenes	2007
Non-parametric estimation for baseline hazards function and covariate effects with time-dependent covariates. Statistics in medicine, 2007, Feb-20, Volume: 26, Issue:4 Topics: Algorithms; Angiogenesis Inhibitors; Computer Simulation; Data Interpretation, Statistical; Depression; Humans; Interferon-alpha; Melanoma; Models, Statistical; Paroxetine; Patient Dropouts; Statistics, Nonparametric	2007
Reduced platelet [3H]paroxetine binding in anorexia nervosa: relationship to eating symptoms and personality pathology. Psychiatry research, 2006, Jun-15, Volume: 142, Issue:2-3 Topics: Adolescent; Adult; Anorexia Nervosa; Anxiety; Blood Platelets; Body Mass Index; Bulimia; Depression; Diet, Reducing; Feeding Behavior; Female; Humans; Paroxetine; Personality Disorders; Personality Inventory; Psychometrics; Radioligand Assay; Serotonin Plasma Membrane Transport Proteins; Tritium	2006
Ear dyskinesia. Journal of neurology, neurosurgery, and psychiatry, 2006, Volume: 77, Issue:6 Topics: Botulinum Toxins, Type A; Depression; Dyskinesias; Ear; Electromyography; Female; Humans; Middle Aged; Muscle Contraction; Neuromuscular Agents; Paroxetine; Selective Serotonin Reuptake Inhibitors	2006
Effect of antidepressant drugs on 6-OHDA-treated mice in the FST. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2007, Volume: 17, Issue:3 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biogenic Monoamines; Cerebral Cortex; Citalopram; Depression; Desipramine; Dopamine Uptake Inhibitors; Hippocampus; Hypothalamus; Imipramine; Injections, Intraventricular; Male; Mice; Neostriatum; Oxidopamine; Paroxetine; Swimming	2007
Usefulness of paroxetine in depressed men with paroxysmal atrial fibrillation. The American journal of cardiology, 2006, Jun-15, Volume: 97, Issue:12 Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Depression; Drug Therapy, Combination; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	2006
[Treatment of non-psychotic depression in outpatient clinic]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2006, Volume: 106, Issue:5 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Depression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outpatients; Paroxetine; Treatment Outcome	2006
Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients. Neuropsychobiology, 2006, Volume: 53, Issue:4 Topics: Adult; Antidepressive Agents; Chi-Square Distribution; Depression; Dose-Response Relationship, Drug; Female; Fluvoxamine; Humans; Japan; Male; Middle Aged; Paroxetine; Receptors, Serotonin, 5-HT2; Retrospective Studies; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index	2006
Alopecia areata with comorbid depression: early resolution with combined paroxetine-triamcinolone treatment. Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:8 Topics: Adult; Alopecia Areata; Antidepressive Agents, Second-Generation; Depression; Drug Therapy, Combination; Female; Humans; Paroxetine; Triamcinolone	2006
Night sweats and elevated follicle-stimulating hormone levels while taking selective serotonin reuptake inhibitors. Obstetrics and gynecology, 2006, Volume: 108, Issue:3 Pt 2 Topics: Adult; Depression; Female; Fluoxetine; Follicle Stimulating Hormone; Humans; Infertility, Female; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sweating	2006
Statistical analysis of longitudinal psychiatric data with dropouts. Journal of psychiatric research, 2007, Volume: 41, Issue:12 Topics: Antidepressive Agents; Clinical Trials as Topic; Depression; Humans; Likelihood Functions; Longitudinal Studies; Mental Disorders; Nortriptyline; Paroxetine; Patient Dropouts; Randomized Controlled Trials as Topic; Regression Analysis	2007
Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:6 Topics: Affect; Animals; Antidepressive Agents; Clinical Trials as Topic; Depression; Desipramine; Drug Design; Hostility; Humans; Motor Activity; Paroxetine; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Treatment Outcome	2006
[A case of Parkinson's disease with neuroleptic malignant syndrome induced by paroxetine]. Rinsho shinkeigaku = Clinical neurology, 2006, Volume: 46, Issue:8 Topics: Aged; Depression; Female; Humans; Neuroleptic Malignant Syndrome; Parkinson Disease; Paroxetine; Selective Serotonin Reuptake Inhibitors	2006
Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Mar-30, Volume: 31, Issue:2 Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depression; Drug Synergism; Female; Humans; Indoles; Isoindoles; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Thiazoles	2007
SSRI antidepressants and birth defects. Prescrire international, 2006, Volume: 15, Issue:86 Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cohort Studies; Cost-Benefit Analysis; Denmark; Depression; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Sweden; Teratogens; United States	2006
[A comparative study of efficacy and tolerability of antidepressants from different classes in mild and moderate depression]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2006, Volume: 106, Issue:11 Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Depression; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Severity of Illness Index; Thiazepines; Treatment Outcome	2006
Selective serotonin reuptake inhibitors reduce the attack frequency in familial mediterranean Fever. The Tohoku journal of experimental medicine, 2007, Volume: 211, Issue:1 Topics: Acute-Phase Reaction; Adolescent; Adult; Blood Sedimentation; C-Reactive Protein; Colchicine; Depression; Drug Therapy, Combination; Familial Mediterranean Fever; Female; Fibrinogen; Fibromyalgia; Fluoxetine; Humans; Leukocyte Count; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2007
Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety. Biological psychiatry, 2007, Mar-15, Volume: 61, Issue:6 Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Anxiety; Brain; Depression; Immobility Response, Tonic; Male; Paroxetine; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Statistics, Nonparametric; Stress, Psychological	2007
[Case report of an elderly woman who developed a pain disorder following her husband's death]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2006, Volume: 108, Issue:11 Topics: Aged; Antidepressive Agents, Second-Generation; Death; Depression; Female; Genitalia, Female; Humans; Life Change Events; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Spouses; Treatment Outcome	2006
Determination of paroxetine in human saliva by reversed-phase high-performance liquid chromatography with UV detection. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2007, Volume: 27, Issue:1 Topics: Antidepressive Agents, Second-Generation; Biomarkers; Chromatography, High Pressure Liquid; Depression; Drug Monitoring; Humans; Paroxetine; Patient Compliance; Saliva	2007
Neonatal convulsions secondary to paroxetine withdrawal. JPMA. The Journal of the Pakistan Medical Association, 2007, Volume: 57, Issue:3 Topics: Antidepressive Agents, Second-Generation; Depression; Diagnosis, Differential; Epilepsy, Benign Neonatal; Female; Humans; Infant, Newborn; Male; Maternal Exposure; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications	2007
Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2007, Volume: 17, Issue:11 Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Body Weight; Depression; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Food Preferences; Glucocorticoids; Male; Paroxetine; Rats; Rats, Wistar; Stress, Psychological; Time Factors	2007
Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients. PharmacoEconomics, 2007, Volume: 25, Issue:10 Topics: Aged; Aged, 80 and over; Algorithms; Bayes Theorem; Citalopram; Cost-Benefit Analysis; Depression; Drugs, Generic; Female; Fluoxetine; Humans; Male; Medicare; Models, Statistical; Paroxetine; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States	2007
Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy. The pharmacogenomics journal, 2009, Volume: 9, Issue:1 Topics: Antidepressive Agents; Depression; Humans; Paroxetine; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome	2009
[Paroxetine-induced hyponatremia in an elderly man due to the syndrome of inappropriate secretion of antidiuretic hormone]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2008, Volume: 45, Issue:1 Topics: Aged, 80 and over; Depression; Diagnosis, Differential; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors	2008
Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment. Psychopharmacology, 2008, Volume: 199, Issue:1 Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Depression; Drinking; Escape Reaction; Exploratory Behavior; Fear; Helplessness, Learned; Injections, Intraperitoneal; Long-Term Care; Male; Mental Recall; Mice; Motivation; Motor Activity; Paroxetine; Pattern Recognition, Visual; Recognition, Psychology; Stress, Psychological; Sucrose; Taste	2008
[Fluoxetine in perspective]. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1994, Volume: 84, Issue:6 Topics: Amitriptyline; Depression; Double-Blind Method; Fluoxetine; Humans; Paroxetine	1994
Parkinsonism exacerbated by paroxetine. Neurology, 1994, Volume: 44, Issue:12 Topics: Adult; Depression; Female; Humans; Parkinson Disease; Paroxetine	1994
New drugs. In the realm of the brain. The American journal of nursing, 1993, Volume: 93, Issue:8 Topics: Central Nervous System Agents; Depression; Humans; Hypnotics and Sedatives; Migraine Disorders; Paroxetine; Pyridines; Sleep Initiation and Maintenance Disorders; Sumatriptan; Zolpidem	1993
Paroxetine: a new selective serotonin uptake inhibitor for depression. The Nurse practitioner, 1993, Volume: 18, Issue:9 Topics: Depression; Humans; Paroxetine	1993
Incentive bias? The Journal of clinical psychiatry, 1996, Volume: 57, Issue:6 Topics: 1-Naphthylamine; Clinical Trials as Topic; Depression; Drug Administration Schedule; Drug Costs; Drug Industry; Financial Support; Humans; Paroxetine; Prejudice; Selective Serotonin Reuptake Inhibitors; Sertraline	1996
Hyperglycemia associated with paroxetine. Annals of internal medicine, 1996, Nov-01, Volume: 125, Issue:9 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Hyperglycemia; Paroxetine	1996
SIADH caused by paroxetine. The Annals of pharmacotherapy, 1996, Volume: 30, Issue:12 Topics: Aged; Depression; Humans; Inappropriate ADH Syndrome; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors	1996
Protective effect of citalopram against the attenuation of the alpha 1-potentiation of cAMP formation in Fischer 344 strain rats. Behavioural brain research, 1997, Volume: 83, Issue:1-2 Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Citalopram; Cyclic AMP; Depression; Imipramine; Male; Motor Activity; Nerve Tissue Proteins; Paroxetine; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, Adrenergic, alpha-1; Selective Serotonin Reuptake Inhibitors; Stress, Psychological	1997
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology, 1997, Volume: 129, Issue:3 Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal	1997
[The concept of therapeutic use of Paroxetin proves to be successful in clinical practice]. Der Nervenarzt, 1995, Volume: 66, Issue:3 Suppl Topics: Aged; Antidepressive Agents; Depression; Depressive Disorder; Geriatric Psychiatry; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	1995
Efficacy of paroxetine for the treatment of depression in the context of HIV infection. Pharmacopsychiatry, 1997, Volume: 30, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; HIV Infections; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales	1997
Paroxetine-induced mania. Journal of the American Academy of Child and Adolescent Psychiatry, 1997, Volume: 36, Issue:6 Topics: Adolescent; Antidepressive Agents; Bipolar Disorder; Depression; Humans; Lithium Carbonate; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors	1997
High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains. Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:8-9 Topics: Adolescent; Adult; Aged; Binding Sites; Brain; Depression; Female; Humans; Imipramine; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Suicide	1997
Individual differences in response to imipramine in the mouse tail suspension test. Psychopharmacology, 1997, Volume: 134, Issue:4 Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Depression; Desipramine; Disease Models, Animal; Imipramine; Individuality; Male; Mice; Mice, Inbred Strains; Motor Activity; Paroxetine; Restraint, Physical	1997
Serotonin syndrome in a prisoner. Journal of forensic sciences, 1998, Volume: 43, Issue:1 Topics: Antidepressive Agents, Second-Generation; Ataxia; Confusion; Depression; Drug Interactions; Forensic Psychiatry; Humans; Male; Mental Disorders; Middle Aged; Paroxetine; Prisoners; Psychotropic Drugs; Risk Factors; Selective Serotonin Reuptake Inhibitors; Syndrome	1998
SSRI supplementation of antimanic medication in dysphoric mania. Pharmacopsychiatry, 1998, Volume: 31, Issue:1 Topics: Adult; Antimanic Agents; Bipolar Disorder; Depression; Drug Therapy, Combination; Female; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	1998
Spontaneous ecchymoses due to paroxetine administration. The American journal of medicine, 1998, Volume: 104, Issue:2 Topics: Antidepressive Agents, Second-Generation; Depression; Ecchymosis; Female; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors	1998
[Depression and Down syndrome]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1998, May-30, Volume: 118, Issue:14 Topics: Adolescent; Antidepressive Agents, Second-Generation; Depression; Down Syndrome; Female; Humans; Paroxetine	1998
Serotonin syndrome following the administration of tramadol with paroxetine. International journal of geriatric psychiatry, 1998, Volume: 13, Issue:5 Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Autonomic Nervous System Diseases; Central Nervous System Diseases; Depression; Drug Interactions; Female; Humans; Pain; Paroxetine; Selective Serotonin Reuptake Inhibitors; Syndrome; Tramadol	1998
Depressive symptomatology during clozapine treatment: two case reports. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1998, Volume: 8, Issue:3 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Clozapine; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Schizophrenia	1998
Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected? European journal of pharmacology, 1998, Jul-03, Volume: 352, Issue:1 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Drug Therapy, Combination; Exploratory Behavior; Hypothermia; Male; Olfactory Bulb; Paroxetine; Pindolol; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists	1998
Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test. Psychopharmacology, 1998, Volume: 138, Issue:2 Topics: Animals; Antidepressive Agents; Buspirone; Citalopram; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming	1998
Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine. British journal of pharmacology, 1998, Volume: 125, Issue:3 Topics: Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Depression; Desipramine; Hippocampus; Injections, Intravenous; Iontophoresis; Male; Norepinephrine; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride	1998
Antidepressant utilization in managed care: an evaluation of SSRI use in two HMO settings. Medical interface, 1995, Volume: 8, Issue:8 Topics: 1-Naphthylamine; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Drug Costs; Drug Utilization Review; Fluoxetine; Humans; Managed Care Programs; Models, Organizational; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; United States	1995
Pharmacoeconomic issues in the treatment of depression. Formulary (Cleveland, Ohio), 1995, Volume: 30 Suppl 1 Topics: Algorithms; Antidepressive Agents; Cost of Illness; Cost-Benefit Analysis; Depression; Drug Costs; Humans; Imipramine; Models, Economic; Paroxetine; United States	1995
Treatment of vocally disruptive behaviour of multifactorial aetiology. International journal of geriatric psychiatry, 1999, Volume: 14, Issue:4 Topics: Aged; Akathisia, Drug-Induced; Behavior Therapy; Dementia; Depression; Female; Homes for the Aged; Humans; Mental Disorders; Noise; Nursing Homes; Paroxetine; Patient Compliance; Physical Therapy Modalities; Psychomotor Agitation; Restraint, Physical; Risperidone; Verbal Behavior	1999
Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat. Pharmacology, biochemistry, and behavior, 1999, Volume: 63, Issue:2 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents, Second-Generation; Depression; Disease Models, Animal; Drug Synergism; Exploratory Behavior; Hypothermia; Male; Motor Activity; Olfactory Bulb; Paroxetine; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists	1999
Paroxetine and its uses in psychiatry. Hospital medicine (London, England : 1998), 1999, Volume: 60, Issue:5 Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Depression; Drug Interactions; Humans; Mental Disorders; Obsessive-Compulsive Disorder; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders	1999
Behavioral changes in developing mice after prenatal exposure to paroxetine (Paxil) American journal of obstetrics and gynecology, 1999, Volume: 181, Issue:5 Pt 1 Topics: Aggression; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Body Weight; Depression; Exploratory Behavior; Female; Homing Behavior; Litter Size; Male; Maternal Exposure; Mice; Motor Activity; Paroxetine; Play and Playthings; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Selective Serotonin Reuptake Inhibitors; Sleep; Time Factors; Vocalization, Animal	1999
An 87-year-old woman taking a benzodiazepine, 1 year later. JAMA, 1999, Nov-24, Volume: 282, Issue:20 Topics: Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Depression; Drug Therapy, Combination; Female; Humans; Paroxetine; Risk	1999
Venlafaxine and paroxetine in treatment-resistant depression. The British journal of psychiatry : the journal of mental science, 1999, Volume: 175 Topics: Cyclohexanols; Depression; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	1999
[Withdrawal syndrome after the use of serotonin reuptake inhibitors]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2000, Mar-20, Volume: 120, Issue:8 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Depressive Disorder; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome	2000
[Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine]. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie, 2000, Volume: 28, Issue:2 Topics: Antidepressive Agents, Tricyclic; Child; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluvoxamine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tics; Tourette Syndrome; Treatment Outcome; Trimipramine	2000
The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome. Psychiatry research, 2000, Dec-04, Volume: 97, Issue:1 Topics: Aged; Aging; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Depression; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Predictive Value of Tests; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Deprivation; Treatment Outcome	2000
Treatment of mild depression in elderly patients. JAMA, 2000, Dec-20, Volume: 284, Issue:23 Topics: Aged; Antidepressive Agents, Second-Generation; Dementia; Depression; Dysthymic Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2000
Treatment of mild depression in elderly patients. JAMA, 2000, Dec-20, Volume: 284, Issue:23 Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Dysthymic Disorder; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2000
By the way, doctor. I've been taking Paxil for depression for about six months. Although it's helped my symptoms of depression, I've lost interest in sex. Aside from stopping the medication, is there any way to regain my sexual function? Harvard women's health watch, 2001, Volume: 8, Issue:6 Topics: Antidepressive Agents, Second-Generation; Depression; Female; Humans; Libido; Paroxetine; Selective Serotonin Reuptake Inhibitors	2001
Dopaminergic sensitivity and prediction of antidepressant response. Journal of psychopharmacology (Oxford, England), 2000, Volume: 14, Issue:4 Topics: Antidepressive Agents, Second-Generation; Apomorphine; Depression; Dopamine Agonists; Human Growth Hormone; Humans; Paroxetine; Predictive Value of Tests	2000
Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:1 Topics: Adult; Depression; Female; Fluorine Radioisotopes; Humans; Male; Paroxetine; Prefrontal Cortex; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Spiperone; Tomography, Emission-Computed; Treatment Outcome	2001
Disinhibition of libido: an adverse effect of SSRI? Journal of affective disorders, 2001, Volume: 62, Issue:3 Topics: Adult; Adverse Drug Reaction Reporting Systems; Citalopram; Depression; Female; Humans; Libido; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Switzerland	2001
Salmon calcitonin potentiates the analgesia induced by antidepressants. Pharmacology, biochemistry, and behavior, 2001, Volume: 68, Issue:1 Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Brain Chemistry; Calcitonin; Depression; Dose-Response Relationship, Drug; Drug Synergism; Hydroxyindoleacetic Acid; Male; Mice; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming	2001
No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients. Neuropsychobiology, 2001, Volume: 43, Issue:3 Topics: Adolescent; Adult; Aggression; Carrier Proteins; Child; Depression; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sex Factors	2001
Prefrontal changes and treatment response prediction in depression. Seminars in clinical neuropsychiatry, 2001, Volume: 6, Issue:2 Topics: Adult; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Sertraline; Venlafaxine Hydrochloride	2001
Cancer fatigue: one drug fails but more are in the pipeline. Journal of the National Cancer Institute, 2001, Jun-20, Volume: 93, Issue:12 Topics: Clinical Trials as Topic; Depression; Dexamethasone; Fatigue; Humans; Neoplasms; Paroxetine; Prednisolone; Selective Serotonin Reuptake Inhibitors; Treatment Failure	2001
Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology, 2001, Volume: 155, Issue:4 Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depression; Desipramine; Dopamine; Extracellular Space; Male; Microdialysis; Nucleus Accumbens; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Swimming	2001
Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study. Cerebrovascular diseases (Basel, Switzerland), 2001, Volume: 12, Issue:3 Topics: Activities of Daily Living; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Case-Control Studies; Depression; Disabled Persons; Female; Fluoxetine; Humans; Male; Middle Aged; Motor Activity; Paroxetine; Recovery of Function; Stroke; Stroke Rehabilitation	2001
Drugs or psychotherapy for the elderly? The Harvard mental health letter, 2001, Volume: 18, Issue:4 Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Humans; Paroxetine; Psychotherapy	2001
[Clinical characteristics and psychotropic therapy of depressive and anxious symptoms of patients with somatic diseases]. Zhonghua yi xue za zhi, 1999, Volume: 79, Issue:7 Topics: Adolescent; Adult; Anxiety; Depression; Female; Hospitals, General; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychophysiologic Disorders; Selective Serotonin Reuptake Inhibitors	1999
[Paroxetine (paxil): use in clinical practice]. Voenno-meditsinskii zhurnal, 2002, Volume: 323, Issue:1 Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Depression; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors	2002
Cross-sensitivity between paroxetine and sertraline. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:4 Topics: Adult; Depression; Drug Eruptions; Exanthema; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2002
Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome. Irish medical journal, 2002, Volume: 95, Issue:1 Topics: Adrenal Cortex Hormones; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Churg-Strauss Syndrome; Cyclohexanols; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Paroxetine; Risperidone; Venlafaxine Hydrochloride	2002
SSRIs: take your pick. The Harvard mental health letter, 2002, Volume: 18, Issue:11 Topics: Depression; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	2002
Modulation of [3H]paroxetine binding to the 5-hydroxytryptamine uptake site in an animal model of depression. Journal of neurochemistry, 1991, Volume: 56, Issue:5 Topics: Animals; Binding Sites; Depression; Male; Paroxetine; Piperidines; Rats; Receptors, Serotonin; Reference Values; Serotonin Antagonists; Tritium	1991